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The lymphatic system runs in parallel with the blood vasculature, it plays a key role in 
maintaining tissue fluid homeostasis, as a tissue-drainage system, and it contributes to 
the immunosurveillance by providing a route for migrating cells. The lymphatic system 
is a highly branched network of thin-walled blind-ended vessels, which drain fluid, 
macromolecules and cells from the extracellular spaces within most organs, carrying 
them into larger thicker-walled collectors running deeper in the body. Fluid and solutes 
extravasated from vascular capillaries into the interstitial space enter blind-ended initial 
lymphatics, which are anchored to the interstitial matrix via anchoring filaments and 
possess overlapping endothelial cell-cell junctions behaving like valve structures, only 
permitting unidirectional lymph entry into the lymphatic vessel lumen. Valves in 
collecting lymphatics consist of two modified adjacent endothelial cell leaflets which 
meet in the vessel lumen forming a funnel inside the vessel and separating adjacent 
lymphangions, the functional units of the lymphatic system. Lymph is formed along a 
hydraulic pressure gradient developing between the interstitial tissue and the lumen of 
initial lymphatics.  This pressure gradient depends upon both extrinsic and intrinsic 
pump systems. Tissue movements provide the extrinsic factor affecting lymphatic 
function, causing cycles of external compression/expansion of the lymphatic vessels 
lumen.. Lymphangions, segments of lymphatic vessel delimited by unidirectional valves 
and surrounded by smooth muscle cells, represent the functional units of the intrinsic 
pump mechanism. Their rhythmic active contraction is essential to guarantee the correct 
lymph flow either as the only source of pressure gradient formation or along with the 
extrinsic pump, where the mechanical features of the surrounding tissue are able to 
generate such an external pump action. During active contraction, lymphatic smooth 
muscle cells create an increase in intraluminal pressure and generate a local positive 
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pressure gradient which drives lymph propulsion. The subsequent relaxation of the 
smooth muscle layer generates a decrease in intraluminal pressure which drives lymph 
from the interstitial space into the vessel itself.  
The aim of the present thesis was to study the interaction between the intrinsic and 
extrinsic mechanisms in a highly moving tissue such as the diaphragm. By in vivo 
fluorescence staining of diaphragmatic lymphatics we were able to identify vessels 
organized in loop structures and located both in the tendineous and in the peripheral 
muscle region. Lymphatic loops  were classified into four groups (active, hybrid, 
passive and invariant) according to their functional behavior, forming functionally 
distinct regions. By whole mount immunostaining against smooth muscle actin we 
identified a dense smooth muscle mesh surrounding actively pumping sites, whereas in 
not contracting tracts smooth muscle fibers were more sparsely organized, showing a lot 
of large gaps around the vessel wall. Actively pumping lymphatic sites did not differ in 
diameter from all other classes of vessels. We found that their amplitude of contraction 
was independent on vessel size but strongly correlated to contraction frequency. By 
temporal analysis we were also able to identify trigger sites which controlled the 
diameter change of both other active and passive sites belonging to the same network. 
We then made an extensive study on the temporal correlation of activity among active, 
hybrid and passive sites belonging to the same network, and were able to identify 
trigger regions and follower regions whose behavior was dependent upon their 
respective trigger sites 
Lastly, we started an ongoing project in order to understand the extrinsic pump effect 
due to respiratory and cardiogenic movements on diaphragmatic lymphatic function. By 
locally injecting KCl into the interstitium next to invariant longitudinal and/or 
transverse lymphatics we tested diameter and/or length changes and then intraluminal 
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pressure gradients due to extrinsic forces. Further analysis are required in order to 














1.1 The Lymphatic System 
In vertebrates, two specialized vascular systems have been developed for effective 
circulation: the blood vasculature, which delivers oxygen and nutrients and carries away 
waste products for detoxification, and the lymphatic vasculature, which returns the 
interstitial protein-rich fluid (lymph) to the bloodstream (Fig 1.1). In fact, as the 
complexity of the blood circulatory system increased among higher species in the 
phylogenetic tree, an additional mechanism to clear the tissues from substances not 
absorbed by the blood vascular system has become necessary (1). In teleost fishes, two 
groups of lymphatic vessels can be identified, however, these vessels only occasionally 
have lymph hearts and lack lymphatic unidirectional valves. Lymph hearts, which are 
enlarged portions of lymphatic vessels, posses contractile elements in their vessel wall 
and consequently pulsatile function. The lymphatic vessels are endowed with 
unidirectional valves in their walls in order to prevent fluid backflow and to force 
lymph into the network and then in the veins. Similarly, amphibians and reptiles exhibit 
a pattern of longitudinal lymphatic vessels and most primitive amphibians also have a 
pair of lymph hearts per body segment. Advanced amphibians such as frogs have fewer 
lymph hearts, and amniotes, such as reptiles, birds and mammals, have a dramatically 
decreased number of these structures (1). Transient rudimentary lymph hearts are 
present in a few species of birds, but they are absent in most birds and mammals. 




Figure 1.1 The lymphatic system. It consists of a complex network of blind-ended capillaries (a) which 
drain lymph and collecting vessels (b) which return it back to the venous system. Lymphoid organs are 
also very important, such as lymph nodes which act as filters. Redrawn from (3). 
 
1.1.1 Embryogenesis of the Lymphatic System  
The blood circulatory system is the first functional system formed during embryonic 
development. In vertebrates, the lymphatic vasculature appears once the blood 
vasculature has formed, thus supporting the hypothesis that lymphatics have a blood 
vascular origin (4; 5). During embryonic vasculogenesis angioblasts, the endothelial 
cells precursors which would form the line of blood vessels, originate from mesoderm-
derived progenitor cells called hemangioblasts (6). They aggregate to form the primary 
blood islands: cells in the interior of the island differentiate into hematopoietic ones, 
and those in the periphery differentiate into angioblasts, which will further differentiate 
into the developing head mesenchyma. They then cluster and reorganize to form a 
network of primitive capillary-like structures, later remodeled during angiogenesis, 
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when new arteries and veins form. Angiogenesis consists in vessels sprouting, due to 
extracellular matrix disruption by endothelial cells migrating and proliferating into the 
perivascular space (7), or by splitting from preexisting capillaries and postcapillary 
venules (8). The newly formed blood vessels are stabilized by pericytes, smooth muscle 
cells and a basal lamina. The process of vasculogenesis is restricted to the early stages 
of embryonic development, whereas postnatal angiogenesis occurs during physiologic 
and pathologic neovascularization. In adults, physiologic angiogenesis occurs during the 
female reproductive cycle and in wound healing (9), whereas pathologic angiogenesis is 
involved in a variety of disorders, such as tumor growth and metastasis, diabetic 
retinopathy, rheumatoid arthritis, cardiovascular diseases and psoriasis (10). Two 
theories are proposed about lymphatic development: the first suggests that lymphatic 
endothelium derives from the blood venous one (centrifugal theory) whereas the latter 
suggests that lymphatic endothelium differentiates in situ from primitive mesenchyma 
(centripetal theory) and then acquires connections with the blood vascular system, at a 
limited number of sites (11). The most accepted model indicates that venous identity is 
the endothelial cells default status and, subsequently, VEGF (12; 13; 14; 15) and Notch 
(16; 17) signaling determine arterial fate, resulting in the separation of arterial and 
venous endothelium via ephrinB2/EphB4 signaling (18; 19). This model defines the 
lymphatic system developing from isolated primitive lymphatic sacs originating from 
venous endothelial cells, spreading by these cells which proliferate into the surrounding 
tissues, where peripheral lymphatic capillaries form (4; 5). 
The blood vasculature system alone is not able to initiate lymphatic vasculature 
development and some additional gene products have to be expressed by venous 
endothelium to become progressively able to respond to local lymphatic-inducing 
signals (Fig 1.2). Although the molecular key defining the start of lymphatic endothelial 
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cells differentiation has not yet been clearly identified, the expression of the lymphatic 
vessel endothelial hyaluronan receptor 1 (Lyve1, a CD44 homologue and hyaluronan 
receptor; (20)) by a few cells of the endothelium lining the anterior cardinal vein (in 
mice at E9.0 – 9.5) is commonly considered the first molecular indication that venous 
endothelial cells are able to respond to a lymphatic-inducing signal (21). In fact, in mice 
a few hours after Lyve1 expression in the anterior cardinal vein, the transcription factor 
Prospero-related homeobox 1 (Prox1) can also be found (22). Then, the Prox1-
expressing endothelial cells progenitors start to bud from veins in a polarized manner 
and, subsequently, these cells proliferate and migrate to form embryonic lymphatic sacs 
and the lymphatic vascular network. Indeed, Prox1 expression in the venous 
endothelium provides strong support for the model of a venous origin of the lymphatic 
vasculature (19). In fact, the critical role in lymphatic development played by Prox1 has 
been also confirmed by the evidence that Prox1−/− mouse embryos display multiple 
phenotypic abnormalities, including the complete absence of lymphatic vessels due to 
failure in lymphatic specification (23), and die around mid-gestation (22). Because 
endothelial cells budded from the anterior cardinal vein at E11.0 – 11.5 do not express 
lymphatic markers, whereas they express blood vascular ones (23), Prox1 activity is 
supposed to be required and sufficient to confer the lymphatic endothelial phenotype on 
progenitors cells located in the embryonic veins, which would otherwise remain as 
blood vascular endothelial ones (21; 23). Prox1 can be definitely considered as a master 
control gene inducing the lymphatic phenotype: in fact in vitro studies also show that 
Prox1 overexpression is sufficient to reprogram cultured blood endothelial cells into 
lymphatic ones (24; 25), acting as a repressor of about 40% of blood-specific markers 




Figure 1.2 The model for lymphatic vasculature development. A Lymphatic competence is the 
autonomous ability of venous endothelial cells to respond to a specific, inductive signal; this stage is 
characterized, for example, by the appearance of Lyve1 expressing cells. B Lymphatic differentiation is 
eventually lost in other venous endothelial cells: Prox1 might be crucial for this step. C Lymphatic 
specification occurs independently to venous endothelial cells one. D Finally, lymphatic vessel 
differentiation and maturation occur in a stepwise manner leading to the synthesis of all of the main 
lymphatic system components. Redrawn from (21). 
 
Early during mouse development, VEGFR-3 (Vascular endothelial growth factor-3, 
receptor for VEGF-C and VEGF-D, which are growth factors promoting 
lymphangiogenesis by interacting with VEGFR-3 and activating an intracellular 
tyrosine kinase-dependent signaling cascade) is widely expressed by both lymphatic and 
blood vascular endothelium, including the one of the anterior cardinal vein (26; 27), but 
is subsequently downregulated in blood vasculature (23; 27). VEGFR-3 gene-targeted 
mice exhibit a dramatic blood vascular phenotype, with embryonic lethality at E9.5 due 
to defective remodeling of the primary vascular plexus and incorrect hematopoiesis (26; 
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28). In fact VEGFR-3 inactivation causes cardiovascular failure and embryo lethality 
before the emergence of lymphatic vessels (26): in this case the lymphatic vasculature 
does not form and lymph fails to be drained causing the animal to die, thus highlighting 
the crucial role of this gene product. 
Lymphatic and blood circulatory systems normally remain completely separated , with 
only a connection point, which is the junction between the thoracic duct and the left 
subclavian vein. Separation between the two vascular networks involves the adaptor 
protein SLP-76 and the tyrosine kinase SYK: in fact, mice in which any of these 
proteins have been functionally inactivated exhibit abnormal blood-lymphatic 
connections, embryonic hemorrhage and arteriovenous shunting (29). 
By E14.5, the lymphatic vasculature has spread throughout most of the developing 
mouse embryo by budding and sprouting from the primary lymphatic sacs; however, 
these growing vessels have not yet become fully mature or terminally differentiated 
(21). Then, only near the time of birth, lymphatic vessels express the complete 
molecular markers profile typical of mature, completely differentiated lymphatics (21; 
30). 
 
1.1.2 Anatomy of the Lymphatic System 
The lymphatic system is a highly branched network of thin-walled blind-ended  
capillaries which, in most of the organs, drain fluid, macromolecules and cells from the 
extracellular spaces. Through larger thicker-walled collectors the newly formed lymph 
is then carried centripetally (Fig 1.3) to form the two main lymphatic collecting trunks 
(the thoracic duct or, from the upper right quadrant of the body, into the right lymphatic 
duct) which empty into the venous circulation at the junctions of left or right internal 
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jugular veins and subclavian veins (31). Lymph nodes are interspaced in the collecting 
vessels and act as filters for the lymph as it passes through. At variance with the blood 
vascular system, lymph is transported unidirectionally from peripheral tissues back to 
the blood circulation (32). The lymphatic network is present in most body organs with 
the exception of the central nervous system, the meninges, the eyeball (except the 
conjunctiva), the orbit, the internal ear, the liver lobule, the spleen pulp, kidney 
parenchyma and avascular tissues, such as cartilage, nails and cuticle (33). 
 
Figure 1.3 Structure of lymphatic vessels. Compared with blood vessels (red), lymphatic vessels (green) 
are thin walled and have a relatively wider lumen. The endothelial cells of lymphatic capillaries lack tight 
junctions, but neighboring cells partly overlap, forming valve-like openings, which allow easy access for 
lymph to the vessel lumen. Fibers known as anchoring filaments connect lymphatic capillaries to the 
surrounding extracellular matrix. The lymph then drains into collecting lymphatics, which eventually 
empty into veins in the jugular region. These collecting vessels have a basement membrane, are 
surrounded by vascular smooth muscle cells and contain intraluminal valves to prevent lymph backflow. 
On its way, lymph content is modified in its passage through lymph nodes. Redrawn from (34). 
 
Fluid and solutes extravasated from vascular capillaries into the interstitial space enter 
blind-ended sacs lined by only a non-fenestrated endothelial layer, which displays 
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numerous invaginations and cytoplasmic vesicles on both luminal and abluminal 
surfaces (35; 36; 37; 38) and it is anchored to the interstitial matrix via anchoring 
filaments. These fibers (whose diameter is in the 6 – 10 nm range) tether the basal 
lamina to adjacent collagen fibers (39; 40) and possess a structure similar to that of 
elastin (41; 42; 43). The initial lymphatics are bulbous sacs (diameter 10 – 60 μm) 
which possess overlapping endothelial cell-cell junctions behaving like valve structures 
(primary valves), only permitting unidirectional lymph entry into the lymphatic vessel 
lumen (Fig. 1.4). They are usually found in a collapsed or partially collapsed state (44; 
45). The lymph then moves into lymphatic vessels of a similar diameter, termed 
lymphatic capillaries, lined by an endothelial layer and a discontinuous basement 
membrane (46), with the exception of lymphatic capillaries in the bat’s wings (47). The 
lymphatic capillary networks greatly vary in shape: anastomoses are usually numerous 
and blind-ends are especially common in the intestinal villi, the dermal papillae and the 
filiform papillae of the tongue. These structures are often organized in two layers: a 
superficial layer and a deeper one, the superficial being of smaller caliber than the deep 
layer. Also, lymphatic capillaries rely on tethering anchoring filaments, to couple them 
to the framework of the extracellular matrix and thus facilitating fluid convection and 





Figure 1.4 Lymphatic valves. A Primary valves in a diaphragmatic initial lymphatic formed by two 
adjacent endothelial cells (E) showing overlapping cytoplasmic extensions (arrowhead) at their junction 
(arrow); M, muscle. B and C Transverse lymphatic ducts showing open (B) or closed (C) secondary 
valves, formed by two leaflet (arrowheads) attached at opposite sides to the lymphatic vessel wall. 
Modified from (48). 
 
Collecting lymphatics (whose diameter is in the 50 – 200 μm range) vessel wall is 
composed by a monolayer of endothelial cells and a basement membrane, but they are 
also surrounded by lymphatic smooth muscle cells and pericytes, not enveloping the 
smaller vessels (49), and possess endothelial intraluminal valves (secondary valves) 
which prevent lymph backflow along the vessel major axis (49; 50). Valves in 
collecting lymphatics differ from the initial lymphatics ones, in fact they consist of two 
modified adjacent endothelial cell leaflets which meet in the vessel lumen (Fig 1.5), not 
unlike bicuspid valves of the larger mammalian venous system. They are made up of a 
thin collagen sheet sandwiched between two endothelial layers and are relatively long 
(about twice the length of the lymphatic vessel cross-section), forming a funnel inside 
the lymphatic and separating adjacent lymphangions, the functional units of the 
lymphatic system. Also, the lymphatic smooth muscle layer is unique, because it 
possesses both tonic and phasic contractile activity (44; 50); in particular, phasic 
spontaneous contractions of lymphatic muscle are involved in lymph propulsion along 
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the intervalvular segments of the lymphatic network. The collecting lymphatics can be 
further classified as prenodal (afferent) or postnodal (efferent), to better specify whether 
they carry lymph to or from the lymph node.  
 
Figure 1.5 Lymphatic vessels: A Blind-ended lymphatic capillaries in adult mouse ear whole mount 
stained for Lyve 1 (green) and smooth muscle actin (red), which identifies smooth muscle cell-covered 
blood but not lymphatic vessels. B Chyle-filled collecting lymphatic vessel in mouse mesentery: arrow 
indicates lymphatic intraluminal valve; arrowhead indicates the blood vessel. Modified from (51). 
 
The thoracic duct has a more complex structure than other collecting lymphatic vessels, 
in fact it presents a distinct subendothelial layer of branched corpuscles, similar to that 
found in the arteries; in the middle coat there is, in addition to the muscular and elastic 
fibers, a layer of connective tissue with fibers arranged longitudinally (33). On its way 
lymph passes through lymphoid organs such as lymph nodes, which consist of a fibrous 
capsule, from which the trabeculae proceeds inward imperfectly dividing the gland into 
open spaces freely communicating with each other, the lymphoid tissue occupying these 
spaces without completely filling them, a free supply of blood vessels, which are 
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supported in the trabeculae and the afferent and efferent vessels communicating through 
the lymph paths in the substance of the gland. Another lymphoid organ is the cisterna 
chyli, which receives the right and left lumbar lymphatic trunks and the intestinal 
lymphatic trunk. The lumbar trunks are formed by the union of the efferent vessels from 
the lateral aortic lymphatic glands: they receive the lymph from the lower limbs, from 
the walls and viscera of the pelvis, from kidney and suprarenal glands and the deep 
lymphatics of the greater part of the abdominal wall (33).  
 
1.1.3 Functions of the Lymphatic System 
The lymphatic system runs in parallel with the blood vasculature, and it plays a key role 
in maintaining tissue-fluid homeostasis, as a tissue-drainage system, and it contributes 
to the immuno-surveillance by providing a route for migrating cells. The terminal 
vessels of this network collect fluid, macromolecules, lymphocytes and antigen-
presenting cells extravasated from the tissues and return them unidirectionally to the 
blood circulation via larger collecting lymphatic vessels (34). Lymphatics are also 
essential for the absorption of long-chain dietary triglycerides and lypophilic 
compounds released in the intestine in the form of chylomicrons. Impairment of the 
lymphatic transport because of abnormal vessels development or damaged vessels 
causes water and proteins stagnation in the interstitial space leading to edematous 
conditions. Moreover, the abnormal function of the lymphatic system contributes to a 
large number of diseases, such as lymphedema, different inflammatory disorders and 
cancer metastasis. In fact, the lymphatic system is also a major transport route for 
immune cells and disseminating tumor cells: while traveling in lymphatic vessels, cells 
and particles undergo lower flow rates and smaller shear stresses than they would 
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experience in the blood circulatory system. Furthermore, the lymph nodes act as holding 
reservoirs where white blood cells can proliferate and disseminating tumor cells form 
metastatic tumors. Indeed, tumor cells more easily penetrate lymphatic vessels than 
blood ones (Fig. 1.6), since the former have looser endothelial cell-cell junctions and 
possess a discontinuous basement membrane (52). On the other hand, for all these 
reasons the lymphatic route might provide several targeting advantages over the blood 
circulation for drug delivery. In particular, there might be a great potential for 
concentrating immunomodulators, chemotherapeutics, and imaging agents to specified 
lymph nodes, avoiding dose-limiting systemic side effects, systemic dilution, and liver 
degradation. 
 
Figure 1.6 Lymphatic invasion by cancer metastasis. A In peripheral lymphatic vessels, or in tumor 
lymphatics, spatial gradients of chemokine-scaffolded extracellular matrix macromolecules interacting 
with lymphatic endothelium may facilitate tumor-cell migration into lymphatic vessels, affecting the 
intra-lymphatic flow (arrows). B Also in the lymph node, a spatial chemokine gradient is present; 
however, both its and trans-lymphatic flow direction are reversed, facilitating extravasation (colonization) 




1.1.4 Lymph formation 
From a structural point of view, the organization of lymphatic vessels into different 
vascular compartments, such as capillaries, precollecting, and collecting lymphatics, 
reflects the dual role of lymphatic system in fluid absorption and lymph transport. In 
fact, two components contribute to the net flow rate in lymphatic vessels, which are 
lymph formation and lymph propulsion. The first describes fluid drainage from the 
interstitium into initial lymphatics, while the second refers to the forces driving lymph 
from initial lymphatics to collecting vessels, through the nodes and ducts, and 
eventually back to the blood. 
The lymphatic system plays an important role in the maintenance of normal interstitial 
fluid volume and fluid protein concentration. Lymph formation is driven by local 
forces, which are interstitial hydrostatic and oncotic pressures and strain of the ECM, 
which can be affected by skeletal motion as well as the slight strains associated with 
pressure oscillations caused by arterial pressure pulsations and vasomotion of 
neighboring arterioles. Lymphatic endothelial cells, like vascular ones, have 
cytoskeletal proteins which permit a variety of active cell shape changes, such as 
pseudopod projection or phagocytosis. But there is no evidence that such cytoplasmic 
motions translate into a contractile mechanism for the entire lymphatic vessel, as in 
collecting ducts equipped with smooth muscle cells within their vessel wall. Thus, the 
compression/expansion cycle depends upon periodic displacement of the tissue 
surrounding initial lymphatics, like that due to skeletal muscle contraction (54). 
The fluid distribution between vascular and interstitial compartments is regulated by 
forces operating across the microvascular wall and the surface area of a permeable 
structure, comprising the endothelial barrier to fluid and solutes, as well as within the 
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extracellular matrix and lymphatic vessels. Under normal conditions the balance of 
these forces favors the net fluid flux from the bloodstream to the interstitial space, a 
process called capillary filtration. Also plasma proteins may cross the microvascular 
barrier and enter the interstitium, thus the lymph flow provides the only route to return 
back these extravasated macromolecules to the blood circulatory system. But if 
extravasated proteins accumulate in the interstitium the balance of forces regulating 
transcapillary fluid filtration is disrupted, resulting in a redistribution of fluid and 
plasma proteins from the vascular space into the interstitial compartment, which is not 
compatible with life. Alterations in the forces acting across the vessel wall and/or the 
surface area and permeability of this barrier allow for moment-to-moment regulation of 
transcapillary fluid flow and thus vascular volume. 
Fluid movement across the vascular capillary wall is driven by the difference in the 
hydrostatic pressure (ΔP) generated by the circulating blood fluid and the oncotic 
pressure (Δπ) exerted by plasma proteins within the capillary lumen relative to that of 
the interstitial space, as stated by the Starling’s Law 
= ∙ ∙ ( − )− ∙ −  (1.1) 
where Jv is the fluid volume filtration rate (nl/sec), Am is the endothelial exchange 
surface area (cm2), Pc is the blood capillary hydrostatic pressure (cmH2O), Pin is the 
interstitial hydrostatic pressure (cmH2O), πp is the plasma oncotic pressure (cmH2O) 
and πi is the interstitial oncotic pressure (cmH2O). In addition, Lp is the hydraulic 
conductivity, a coefficient describing the permeability of the capillary wall to water 
(cm/sec ∙ cmH2O), and σ is the unitless  reflection coefficient, which describes the 
molecular sieving property of the capillary wall (σ = 0 means completely permeable 
without solute reflection back; σ = 1 means completely impermeable with 100% 
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reflection back). For example, the albumin reflection coefficient in subcutaneous 
capillaries is ∼ 0.7, meaning that only 30 % of plasma proteins may cross the capillary 
wall. The major source of capillary transmural oncotic pressure is albumin, with less 
contribution from globulins. Hence, there is an inward-directed oncotic pressure 
gradient across the capillary wall, as well as an outward-directed hydrostatic pressure 
gradient (55; 56). 
The Starling’ Law, derived through thermodynamic analysis from the original 
formulation by Sir Eernest starling (57)  is commonly summarized as: 
= ∙ ∙ [∆ − ∙ ∆ ]  (1.2) 
where ΔP = Pc − Pin, determined by capillary blood pressure relative to the tissue 
interstitial one and Δπ = πp − πin, set by the different concentration of plasma proteins 
inside and outside of the vascular capillary.  
 
Figure 1.7 Forces affecting fluid filtration/reabsorption. Hydrostatic pressure above the oncotic pressure 
gradient results in fluid filtration into the tissue. When the hydrostatic pressure gradient across the vessel 
barrier equals the oncotic pressure gradient there is no net fluid flux (intercept with x axis). If the pressure 
falls below that point, fluid is reabsorbed from the interstitium into the vascular space. The slope of the 
relationship between fluid flux per unit surface area and pressure is the hydraulic conductivity (Lp, 
redrawn from (58)). 
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A positive Pc a negative Pin and the πin favor fluid filtration from the vascular to the 
extravascular compartment; conversely πp and positive Pin tend to retain fluid into the 
vascular space. The graph in Fig 1.7 describes the volume flux per unit of surface area 
(Jv/A) as a function of  the difference in hydrostatic pressure, ΔP, which defines a 
straight line with slope equal to Lp and pressure (x axis intercept) equal to oncotic 
pressure, π. In the microvasculature, the Pc is higher at the arteriolar end (35 – 45 mm 
Hg) than at the venular one (12 – 15 mm Hg, (55). Thus, upstream of the capillary 
network near the arterioles ΔP > Δπ and fluid exits the vessel. However, under 
pathological conditions where Lp is increased and σ decreases, large quantities of 
proteins accumulate in the interstitial space producing an oncotic force which drives 
fluid into the interstitial tissue and prevents fluid reabsorption into the blood circulation, 
leading to edema. 
In most tissues, supplied by the lymphatic network, Pin tends to be subatmospheric  
(between  -10 to  - 1 cmH2O) promoting fluid filtration both at the arteriolar and at 
the venular end of the capillary walls, the filtered fluid being subsequently removed by 







Figure 1.8 Hydrodynamic forces governing fluid flow across the microvessel wall. Fluid movement 
across the capillary wall is driven by Starling’s forces, due to the difference in hydrostatic pressure (ΔP) 
and oncotic pressure (Δπ) between the capillary lumen (c) and the interstitial compartment (i). Fluid and 
proteins filtered out of the capillary accumulate in the interstitial space, decreasing both Pc and πc and 
increasing interstitial pressure. On the contrary, interstitial pressure is decreased by lymphatic outflow. Lp 
is the hydraulic conductivity and σ is the oncotic reflection coefficient. Redrawn from (59). 
 
Instead, in tissues not supplied by lymphatics, such as the nervous system, retina, renal 
medulla and salivary glands, Pin is generally > 0 cmH2O, so that fluid is filtered from 
the arteriolar side of the capillary and reabsorbed into the blood stream at the venular 
end. 
Fluid and macromolecules which cross the microvessel wall and are not reabsorbed  
back into the plasma tend to accumulate in the interstitial space to be removed by 
lymphatic vessels. Starling’s Law also explains the net fluid movement between the 





Indeed, lymph flux (Jl, ml/min) can be expressed as:  
= ∙ ∙ Δ = ∙ ∙ − − ∙ −  (1.3) 
ΔPlymph depends upon hydraulic and oncotic pressures of the lymphatic capillary (Plymph 
e πlinf) and of the interstitial space (Pin e πin). The reflection coefficient σ which varies 
between 1 and 0 in lymphatics is ~ 0, thus none of the solute is reflected at the barrier. 
Hence, the hydraulic pressure gradient alone drives fluid movement 
= ∙ Δ = ∙ −    (1.4) 
where Kl is the lymphatic conductance). Consequently, a positive ΔPTM gradient 
resulting from Pin higher than Plymph, drives fluid flux from the interstitial space into the 
initial lymphatic lumen, opening primary flap valves (Fig 1.9).  
On the contrary, a negative ΔPTM gradient due to higher lymphatic hydraulic pressure 
(Plymph > Pin), for example during lymphangion contraction, would favor the lymph 






Figure 1.9 Mechanism of lymph formation in initial lymphatics. Initial lymphatics drain interstitial fluid 
and macromolecules via openings between lymphatic endothelial cells (LECs), preventing lymph 
backflow into the interstitium. Anchoring filaments attach LECs to the extracellular matrix, preventing 
the vessel to collapse under conditions of increased interstitial pressure (black arrow). Redrawn from 
(60). 
 
This transient pressure gradient coupled with the presence of primary and secondary 
valves allows lymph formation and propulsion due to the compression/relaxation cycle 
of either extrinsic or intrinsic lymphatic pumps, both in initial and in collecting 
lymphatics.The transient change in interstitial and lymphatic pressure in initial 
lymphatic capillaries is sustained by tissue movements, an important factor affecting 
lymphatic function, causing cycles of external compression/expansion of the lymphatic 
vessels lumen. The pressure gradients developed across the lymphatic vessel wall favor 
both fluid drainage from the interstitial space and/or progression of the lymph along the 
lymphatic network (45; 44). A good model to study the initial lymphatic-extracellular 
tissue interaction in the formation and progression of lymph is represented by the 
diaphragmatic lymphatic network, which provides peculiar and unique features, being 
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1.2 The Diaphragm  
The diaphragm is the primary ventilator muscle in humans and consists in a dome-
shaped structure, with a central tendineous region surrounded by a ring of striated 
muscle fibers radially oriented, which except in pathological conditions, completely 
separates the pleural from the abdominal  cavities. The central tendineous region extent 
changes with growth, with a more muscular diaphragm in children than in adults. 
Interestingly, the central tendon is reduced or lacking in certain species, such as the 
polecat and the porpoise (61). From a functional point of view, the diaphragm forms an 
elliptical cylinder (the muscle region) covered by an almost flat dome (the central 
tendineous region). The cylindrical, vertical part of the muscle is in contact with the 
inner face of the lower rib cage, over a “zone of apposition” which occupies 
approximately one third of the total height of the rib cage. The lower ribs are therefore 
exposed to the abdominal pressure and not to the pleural one (62; 63). 
 
Figure 1.10 Diaphragmatic contraction/relaxation. During breathing the thorax volume changes and the 
diaphragmatic contraction compresses the abdominal viscera, causing also the abdominal shape 




The diaphragmatic muscle contraction causes the muscular fibers shortening and the 
diaphragmatic dome descending towards the abdomen (65). At the same time, 
shortening of the diaphragmatic fibers exerts a cranially oriented force on the lower ribs 
(66; 67), allowing their upward movement (68). Together with the contraction of the 
external intercostal muscle, this expands the thoracic cavity by increasing both its 
cranio-caudal and trasverse axis.(Fig 1.10) As a consequence, the pleural pressure 
decreases, thus increasing transpulmonary pressure, decreasing alveolar pressure and 
driving air into the lungs. In addition, the abdominal viscera are pushed caudally, 
increasing the abdominal pressure. The positive abdominal pressure exerts an external 
force to the internal face of the lower ribs. During the expiration phase the 
diaphragmatic muscular fibers passively relax and return to their initial length, thus 
shifting the diaphragm upward towards its end-expiratory state. 
 
1.2.1 Anatomy of the Diaphragmatic Lymphatic System 
The diaphragmatic lymphatic network drains fluid, solutes of large molecular weight, 
and cells from the pleural and the peritoneal cavities, mainly through the peripheral 
vessels located in the parietal mesothelial and submesothelial tissues covering thoracic 
and abdominal walls and both diaphragmatic surfaces (69; 70; 71; 72). Diaphragmatic 
lymphatics depart from pleural and peritoneal cavities through the so called stomata, 
which are mesothelium discontinuities formed at the confluence between mesothelial 
cells (73; 74), and submesothelial lacunae (75) which, for their morphological and 
functional features, may be considered as large initial lymphatics. This extended mesh 
of vessels is hierarchically organized with submesothelial lacunae located within the 
interstitial space beneath the mesothelium (48; 75), lymphatic capillaries located among 
the skeletal muscle fibers, transverse ducts, running perpendicularly from the 
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submesothelial lacunae through the skeletal muscle fibers, and deeper collecting vessels 
which receive the newly formed lymph and eventually empty into larger ducts (Fig 
1.11) functioning as collectors for the lymph to be carried out of the diaphragm through 
extra diaphragmatic trunks, mostly the right and partly the left lymphatic duct.  
Initial lymphatic vessels in the submesothelial interstitium or lymphatic capillaries 
(with a diameter of  1–10 μm) dispersed among muscle fibers display primary 
unidirectional valves in their vessel wall, formed by two adjacent endothelial cells 
linked by overlapping junction, with cytoplasmic extensions partially protruding into 
the vessel lumen. On the contrary, unidirectional intraluminar valves, formed by two 
endothelial cells leaflets attached at opposite sides of the lymphatic vessel wall, are 
commonly detected in collecting and transverse lymphatic ducts departing from both 





Figure 1.11 Diaphragmatic lymphatics anatomy A Semithin cross section of rat diaphragm showing 
diaphragmatic lymphatic network arrangement from pleural (PL) to peritoneal (PE) surfaces. 
Submesothelial lacunae (arrowhead) are located within the interstitial space beneath the mesothelial layer, 
whereas transverse ducts (arrow) run perpendicularly to the lacunae through the muscular fibers (M) and 
central collectors (C) are located in the deep interstitial space. B Small nonerythrocyte-filled lymphatic 
vessels (arrowhead) surround muscle fibers (M) and are distinguishable from blood capillary vessels 
(arrows), which are erythrocyte-filled. Modified from (48). C Scanning electron photomicrograph of a 
lymphatic stoma on the tendineous pleural surface of the rat diaphragm. The stoma (S), delimited by a net 
border, opens at the confluence between adjacent mesothelial cells (MC), which are characterized by a 
mesh of microvilli protruding from the cell surface. Modified from (76). D Cluster of lymphatic stomata 
on the muscular pleural diaphragmatic surface, yet again delimited by a net border. Modified from (73).  
 
Pleural diaphragmatic lymphatics are typically organized into planar submesothelial 
linear vessels or complex loops, where linear tracts merge, forming a bidimensional 
mesh laying on top of the muscular or tendineous diaphragmatic plane (77). The loop 
conformation of lymphatic vessels can also be found in other tissues, such as skeletal 
A B
5 µm C 20 µm D
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muscle (78), where lymphatics run along vascular arteriolar arcades (44), or in the 
mesentery (79). 
Diaphragmatic lymphatic vessels on the pleural side are anatomically distinguishable 
not only for their arrangement, but also for their distribution. In fact, submesothelial 
lymphatic loops are mainly located in the peripheral ventrolateral regions of the 
diaphragm, whereas linear lymphatics are dispersed over the whole diaphragmatic 
surface, apparently connecting different regions and no loops can be found in the medial 
tendineous diaphragmatic region (77). Lymphatics can be visualized under white light 
epi-illumination stereomicroscope beneath the transparent parietal pleura covering the 
diaphragmatic surface and appear as darker-than-background conduits delimited by 
faint white borders. As reported in Fig 1.12, from a single linear vessel, the loop 
branches into shorter ducts placed in parallel and/or in series with each other. Therefore, 
at variance with linear tracts, loops offer multiple paths for fluid recirculation. This kind 
of arrangement seems to be finalized at exploiting the contraction/relaxation phases of 
diaphragmatic muscle fibers to alternatively enhance lymph formation or propulsion 
along the lymphatic network, thus contributing to optimize fluid and solute removal 
from the pleural and peritoneal cavities throughout the entire respiratory cycle (77). 
Unlike the pleural side, on the peritoneal diaphragmatic surface lymphatic vessels are 
organized in distinct areas, which consist of saw-toothed vessels extending radially 
from the central tendon to the thoracic wall. Each area forms a relatively distinct 
functional unit with respect to fluid draining from the serous cavities and the lymphatic 
vessels of the tendineous portion connect either with the serrated lymphatic vessels or 
with peri-esophageal ones (80). 
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The rat diaphragm thickness is almost constant on the whole extent, measuring ~ 750 
μm (48). Similarly, the thickness of the mesothelial monolayers is uniform throughout 
the whole surface, whereas the pleural submesothelial interstitial tissue is significantly 
thicker (~ 35 μm) compared to the peritoneal (~ 20 μm) one (48). Studies on the 
submesothelial lymphatic network immersed into the interstitial space indicate that 
lacunae width and length are comparable when measured on the pleural or on the 
peritoneal side, but their density is higher over the peritoneum compared with the 
pleural one and the arealacunae-to-areatissue (the percentage-wise cross-sectional area 
occupied by the lacunae per unit of submesothelial tissue area) is higher in the 
tendineous compared to the muscular regions of both the ventral and dorsal part of the 
pleural side and in the ventral region of the diaphragmatic peritoneal side of the 
diaphragm (48). These morphological differences between the peritoneal and pleural 
side of the diaphragm might related to the fact that, although the mechanisms 
supporting lymph formation and progression from the two serous cavities into the 
diaphragmatic network are the same, the amount of fluid removed from the peritoneal 




Figure 1.12 Diaphragmatic lymphatic system. A and B Pictures showing different diaphragmatic 
lymphatic vessels arrangement on both pleural (A) and peritoneal (B) side of an ink-stained rat 
diaphragm. Peritoneal submesothelial vessels extend radially and parallel to one another from the central 
tendon to the thoracic wall, with numerous connecting branches, forming distinct areas of lymphatics. On 
the pleural side, lymphatics are arranged in radial and reticular patterns. The radial arrangement is clearly 
evident from the tendon–muscle border to the mid-muscle portion. As they approach the thoracic wall, 
lymphatic vessels extend transverse branches which traverse muscle fibers and interconnect with adjacent 
lymphatics (scale bars = 1 mm). Modified from (80). C and D Stereomicroscope images of pleural 
lymphatics, which  are mainly organized into linear vessels (C) or complex loops (D), showing both 
anatomical and functional divergence. Underneath the lymphatic loop, the diaphragmatic muscular fibers 
are clearly distinguishable and cross the loop almost perpendicularly (scalebars: C = 100 µm, D = 200 
µm). Redrawn from (77). E Picture of the diaphragmatic frontal view. The shaded areas correspond to the 
medial tendineous tissue (light shading) and the peripheral skeletal muscle (dark shading). The dashed 
superimposed lines identify four different regions: (a) ventrolateral area corresponding to ventral 
peripheral muscular portion, (b) medial ventral portion corresponding to ventral tendineous area, (c) 
dorsolateral muscular region and (d) dorsomedial tendineous region. Redrawn from (82). 
 
The different diaphragmatic lymphatics are probably involved in different functions, 
even within the same hierarchical order of vessel, with lymphatic loops acting as a low-
resistance pathway for direct fluid drainage from the serous cavities, and the subsequent 










to transverse and deeper collecting ducts (48; 77). Indeed, recent studies on the fluid 
distribution within the diaphragmatic submesothelial lacunae suggest that lymphatic 
loops in the muscular periphery may be the preferential sites of fluid entrance into the 
diaphragmatic lymphatic network. 
In thoracic tissues, lymph formation and progression seem to mostly depend upon 
compressive or expansive external forces, squeezing and enlarging lymphatic vessel 
lumen, due to the tissue displacement by the beating heart or by the 
contraction/relaxation of respiratory muscles (83; 84; 85). In the pleural diaphragmatic 
lymphatic network lymph formation depends upon the pressure gradient between 
pleural fluid (Pliq) and intraluminal hydraulic lymphatic pressure (Plymph). At end-
expiration, the peripheral diaphragmatic muscular fibers are relaxed and passively 
stretched by the pulling action of the stiffer central tendon fibers. This condition, 
coupled with the sub-atmospheric diaphragmatic Pliq, might distend the superficial 
lymphatics oriented transversally to the muscular fibers and reduce Plymph, favoring end-
expiratory lymphatic filling. Then, on inspiration, the muscular fibers contract and 
shorten and the central tendineous fibers are stretched while diaphragmatic Pliq 
decreases (86), a condition that, by limiting lymph formation, might instead favor 
lymphatics squeezing and lymph propulsion along the network. On the other end, in 
lymphatics running through soft compliant tissues, a well-developed vessel wall 
equipped with a smooth muscle layer is required to generate the transmural pressure 
gradients affecting lymph formation and intraluminal pressure waves to correctly propel 
the lymph through the entire network, and also the phasic changes of wall stiffness 
favoring lymphangion filling, smooth muscle diastole and lymph propulsion along the 




1.2.2 Mechanical features of the diaphragmatic lymphatics 
Two populations of diaphragmatic lymphatics, not distinguishable on the basis of their 
orientation over the diaphragmatic surface, but all running perpendicularly to the 
underlying muscular fibers, have been identified on the diaphragmatic pleural surface, 
having high compliance (index of vessel wall distensibility, indicated as volume change 
for a given pressure range; H-Clymph amounting ~ 7 nl/mmHg) or low compliance (L-
Clymph amounting to ~ 2 nl/mmHg). Based on these data, three ideal initial 
diaphragmatic lymphatics can be modeled: a superficial lymphatic laying over the 
muscular/tendineous plane and delimited almost entirely by the mesothelium, an 
intermediate lymphatic still partially delimited on one side by the mesothelium, but 
surrounded by the muscular/tendineous tissue over most of its lateral surface, and a 
lymphatic completely immersed in the muscular/tendineous tissue. Clymph-M for a deep 
vessel with ellipsoidal cross-sectional shape is extimated ∼100- and ∼20-fold smaller 
than measured H-Clymph and L-Clymph, respectively. The model suggests that tensile 
stress is higher in the more compliant wall of the submesothelial superficial and 
intermediate lymphatics, compared to the one of deeper initial lymphatics (Fig 1.13). 
The highest tensile stress can be found in intermediate lymphatics, at the edges between 
the compliant wall and the stiff diaphragmatic tissue basement which undergoes the 
greatest deformation, whereas in deep, stiffer lymphatics, in particular with a circular 
shape, wall tension is lower and more homogenously distributed over the entire surface. 
According to these models, the mechanical properties and functions of initial 
lymphatics may depend upon surrounding tissue stiffness. Submesothelial lacunae 
delimited by a compliant wall probably serve as reservoirs of drained fluid, while 
deeper vessels running in the stiffer tissue, particularly those with a circular cross-
sectional shape like the large vessels in the deep diaphragmatic interstitium (48) present 
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an homogeneous wall stress distribution which, combined with the low compliance and 
with unidirectional valves, provides a more efficient structure able to propel fluid along 
the network (76). In relaxed isolated mesenteric lymphatics Clymph is intermediate (87) 
between submesothelial and deep diaphragmatic vessel, suggesting that the smooth 
muscle layer may not only sustain active lymphatic pumping, but also provides a 
relatively stiff mechanical support to lymphatic vessels immersed in soft tissues. 
 
Figure 1.13 Three-dimensional modeling of the diaphragmatic lymphatic vessel wall highlighting the 
stress distribution map. A Ellipsoidal superficial vessel located immediately beneath the mesothelium, 
which is delimited mostly by a thin wall of lymphatic endothelium plus pleural mesothelium and lays on 
a diaphragmatic muscular/tendineous support. B Intermediate lymphatic duct deeper in the 
submesothelial tissue, which is only partially delimited by a thin wall, but most of the lateral surface is 
surrounded by the muscular/tendineous tissue. C Ellipsoidal deep lymphatic located among the 
diaphragmatic muscular/tendineous fibers and surrounded by an isotopic tissue. D Circular deep 
lymphatic vessel among the diaphragmatic muscular/tendineous fibers surrounded by an isotopic tissue. 
The circumferential stress distribution is represented by color key from blue (low stress) to red (high 




Consequently, cyclic contraction and relaxation of either skeletal and/or smooth muscle 
cells in the vessel wall may support lymphatic function by favoring the development of 
transmural pressure gradients, which sustain lymph formation and propulsion along the 
network, and by modifying the mechanical features of the lymphatic vessel wall, 
increasing the efficiency of the lymph formation/lymph propulsion phases.  
The transmission of forces and displacement from the perivascular tissue to the wall of 
the initial lymphatic is guaranteed by the mechanical links provided by the anchoring 
filaments  (88; 89) which connect the outer endothelial cell surface to the extracellular 
matrix fibers (90; 91; 92)  Indeed, in skeletal muscles such as the  diaphragm, the 
lymphatic endothelium runs at close proximity with the interstitial collagen fibers and 
with the skeletal muscle fibers (Fig1.14), thus optimizing the anchoring filament 
function and the force transmission to the lymphatic lumen.  
 
Figure 1.14 Pictures highlighting the anatomical proximity of initial lymphatic lumen and interstitial 
fibrillar structures. A and B Transmission electron microphotographs of rat diaphragm. Initial lymphatics 
(L) run through connective tissue composed of loose collagen fibers which are organized in bundles (b) 
adjacent to the skeletal muscular fibers (c). These vessels are characterized by thin endothelial wall (d), 
tight junctions or overlapping leaflets and anchoring filaments linking the endothelial cells to the adjacent 
collagen fibers and to the muscle fiber sarcolemma. a, vascular capillary endothelium; e, fibroblast. 





Based on the peculiar arrangement and experimental accessibility of the pleural 
diaphragmatic lymphatic network, it has been possible to directly measure Pin and Plymph 
in rodents to verify, in situ and in vivo, the existence of a net ΔPTM  supporting lymph 
formatin from the diaphrgamtic interstium to the initial lymphatics (Fig.1.15) .  
 
Figure 1.15 Effect of cardiac and respiratory activity on interstitial (Pint) and lymphatic (Plymph) fluid 
pressure. A cardiogenic oscillations of diaphragmatic interstitial (b, Pint) and intraluminal lymphatic 
pressure (c, Plymph), measured in rats under neuromuscular blockade. Both diaphragmatic Pint and Plymph 
oscillate almost in phase with systemic arterial pressure (a), shifting from a minimum to a maximum 
value during cardiogenic oscillations. Taken from (83; 93). B simultaneous recording of respiratory tidal 
volume (VT, top panel) and lymphatic (Plymph; continuous lines) and interstitial (Pint; dashed lines) 
pressures obtained in intercostal lymphatics of anesthetized and spontaneously breathing rats showing a 
variable pressure gradient from the interstitium to the lymphatic vessel.  Redrawn from (93; 84). 
 
Data show that both Plymph and Pin oscillates in phase with the cardiac activity and that, 
since Plymph is physiologically lower than Pin, a net ΔPTM does exist sustaining lymph 
formation. Therefore, the extrinsic mechanism supported by to the tissue displacement 
associated to the cardiac motion can , per se, provide a source of lymphatic flux in the 
diaphragm.   
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1.3 Lymph propulsion 
Lymph propulsion through lymphatic vessels is affected by local forces but, on the 
other hand, it also depends upon systemic forces such as respiration (44; 81; 94; 95) 
blood pressure (96), exercise (97), and massage (98; 99; 100). In addition, lymph 
formation rates may indirectly affect lymph propulsion since the lymphatic smooth 
muscle contraction of collecting vessels is stretch-sensitive (97; 101; 102). 
Since the lymphatic transport is not circuitous and the prevailing steady-state pressures 
do not support lymph formation or lymph flow along the lymphatic network, 
intraluminal unidirectional valves play a pivotal role preventing lymph backflow (Fig 
1.16). 
 
Figure 1.16 Lymphatic valves functioning. A Schematic diagram of primary and secondary valve 
opening during the expansion (E) and a compression (C) phase of a lymphatic vessel. Primary valves in 
the initial lymphatic open during the filling phase (E), facilitating interstitial fluid to enter the vessel. But 
the secondary (intralymphatic) valves in the collecting lymphatic are closed to prevent lymph backflow. 
During the compression phase primary valves close to prevent lymph backflow into the interstitium while 
the secondary valves open to facilitate lymph propulsion towards the entire network. Redrawn from 
(103). B Schematic diagram of the intraluminal valve funnel arrangement. Funnel (F) consists of a thin 
connective tissue sheet covered by lymphatic endothelium. Funnel inversion is prevented by the 
attachment to the lymphatic wall via two buttresses. Flow is in direction of the arrow. Schematics of 





In fact, there is no single pump in the lymphatic system as there is in the cardiovascular 
system where the energy of the heart’s contractions is enough to propel blood through 
the entire circulatory system. On the other hand, the lymphatic system possesses 
numerous intrinsic pumps, called lymphangions, which contract to guarantee the correct 
lymph flow in the majority of mammals, and represent the functional units of the 
lymphatic system (Fig1.17). Since the driving force created by a single lymphangion is 
not enough to propel the lymph through the entire lymphatic system, lymphatic vessels 
are organized in chains of these kind of pumps. 
 
Figure 1.17 Mechanism of lymph propulsion in collecting vessels. Coordinated opening and closure of 
lymphatic valves is important for efficient lymph transport. Smooth muscle cells covering each 
lymphangion possess intrinsic contractile activity. EC, endothelial cell. Redrawn from (60). 
 
There is no evidence that in any regional lymphatic network lymphatic tracts contract 
simultaneously along all of their length from capillaries to the local collecting output. 
On the contrary, numerous reports demonstrate the propagation of coordinated 
peristaltic-like pumping waves along the lymphatic network (105; 106). Moreover, in 
some regional lymphatic networks (as those in the lower limbs), the presence of an 
interrupted fluid column in lymphatic vessels has been demonstrated during the normal 
contractile activity of lymphangions; in such situations adjacent lymphangions contract 
in counter-phase fashion (107). Consequently, each lymphangion can be described as a 
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short-distance local pump whose primarily task is to drive a bolus of lymph only to fill 
the adjacent or few next ones. However, all together the pumps chains are able to 




1.4 Intrinsic and extrinsic lymphatic pumps 
The lymphatic system function relies upon a combination of intrinsic and extrinsic 
pumps, which act in order to generate lymph flow and changes in lymphatic tone to 
modulate lymph flow resistance. There are several forces affecting lymphatic functions. 
Traditionally, they are divided into two groups based on their motive force. The active, 
or intrinsic, lymphatic pump refers to the forces generated by the active spontaneous 
phasic contractions of smooth muscle cells in the lymphatic vessels wall. On the 
contrary, the passive, or extrinsic, lymphatic pump combines together all the forces 
generated in the tissue outside the lymphatic vessels wall. 
The lymphatic system possesses multiple intrinsic short-distance pumps 
(lymphangions), the contraction of which is essential to guarantee the correct lymph 
flow. In general, it appears that lymphatic vessels not encased in a parenchymal tissue 
that undergoes regular periodic oscillations in tissue pressure demonstrate regular, 
strong, fast phasic contractions, which drive lymph through the lymphatic network. 
During the active contraction, lymphatic smooth muscle cells create an increase in 
intraluminal pressure and generate a local positive pressure gradient which, aided by the 
unidirectional valves, drives lymph propulsion (Fig 1.18). As a result of such intrinsic 
pumping activity, a positive pressure gradient occurs near the downstream propagating 
zone, whereas at the upstream edge of the contracting tract a negative pressure gradient 
develops between the active lymphangion and the upstream one. This gradient generates 
the short-lasting local reversed flow, which pushes cell leaflets against each other 
closing the valve (105). The majority of the contraction-derived energy is used to 
produce the correct intraluminal pressure gradient and propel the lymph flux, but some 
part of this energy takes part in lymphatic wall tension generation and produces 
deformations in extracellular matrix components such as collagen and elastic fibers. 
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Afterward, during the diastolic phase, these fibers release their stored energy and allow 
the lymphatic vessel to re-expand. Actively driving forces are greatly influenced by 
extra-lymphatic events, which sometimes have a bigger impact on lymph flow than the 
active pump, and the force sum vector is not always favorable to lymph flow.  
 
Figure 1.18 Intrinsic and extrinsic lymphatic pumps. Time course of PL (pressure recorded by the servo-
null pipette in the central chamber, A) and diameter changes (B) during a complete contraction cycle. 
Graphs also show the phase delay between the diameter changes and velocity. Modified from (108). C Pint 
and Plymph in phase oscillation during the cardiogenic cycle delimited by the vertical dotted lines. D The 
net transmural hydraulic pressure gradient (ΔPTM) affecting lymphatic function may be calculated in 
correspondence of the tracings minimum (ΔPTM, min) and maximum (ΔPTM, max) values. E and F 
represent tracings like the ones in C and D respectively, but oscillations are clearly in opposite phase. 
Redrawn from (83). 
 
The extrinsic lymphatic pump refers to all the extra-lymphatic forces influencing lymph 
flow, not related to the active contraction of the lymphatic vessels wall, but generated 
by other forces in the tissue surrounding the vessels. Extrinsic forces include the 
influence of cardiac and arterial pulsations on neighboring lymphatic vessels, the 







fluctuations, gastrointestinal peristalsis and respiratory movements. All of these forces 
may generate hydrostatic pressure gradients in the lymphatic network, to propel the 
lymph flux even without intrinsic contractility (83; 84; 81). 
For example, looking to Fig 1.18, during cardiogenic cycle Pint and Plymph recorded in 
the same vessel can oscillate both in phase (C-D) or in opposite phase (E-F). When they 
oscillate in phase (C), ΔPTM gradient remains constant (D) giving rise to a constant 
lymph flux. On the contrary, when Pint and Plymph oscillate out of phase (E), ΔPTM 
gradient varies with time (F) giving rise to a pulsatile lymph flux. 
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1.5 The Lymphatic Smooth Muscle 
Interstitial fluid and macromolecules enter into the lymphatic system through initial 
lymphatics, which are usually devoid of smooth muscle elements. Lymphatic smooth 
muscle cells appear in the lymphatic network at the level of collecting vessels in most 
tissues and animals (109; 110) with the exception of the bat’s wings (111) where they 
are also found in initial lymphatics. The smooth muscle cells are loosely organized 
where they first appear in the lymphatic network but become oriented into more 
organized layers (Fig 1.19) in the larger collectors (112; 113). In fact, there, they are 
strategically arranged into one to three layers, intermixed with collagen and elastic 
fibers and surrounded by an adventitia made of fibroblasts, connective elements and 
nerve terminals. Generally, from periphery to progressively larger vessels, the amount 
of smooth muscle cells increases and they become more ordered with distinguishable 
layers. The smooth muscle layer may be sometimes interrupted where unidirectional 
valves divide the vessel into lymphangions and exhibits spontaneous phasic brisk and 
strong contractions, leading in some vessels to the complete but transient obstruction of 
the lumen. In fact, the contraction of these cells leads to a rapid reduction of the 
lymphatic diameter, an increase in the local lymph pressure, the closure of the upstream 
intraluminal valve, the opening of the downstream valve and the lymph ejection, 




Figure 1.19 Lymphatic smooth muscle. A Immunofluorescence staining of dermal lymphatic vessels 
using antibodies against lymphatic markers, such as Lyve1 (green) and podoplanin (blue). Taken from 
(114). Red staining shows the α-smooth muscle actin (αSMA), which indicates the smooth muscle cells 
around blood vessels (not counterstained) and collecting lymphatic vessels, but not lymphatic capillaries, 
which are devoid of smooth muscle cells. B Higher magnification of a lymphatic valve, visualised by 
podoplanin (blue) and αSMA (red) double-staining. The smooth muscle mesh is interrupted where the 
intraluminal lymphatic valve divides two adjacent lymphangions. Redrawn from (115). 
 
1.5.1 Lymphatic Smooth Muscle development 
It is likely that the lymphatic endothelium is crucial for smooth muscle recruitment and 
differentiation, regardless of the exact muscle cell origin. In fact, during lymphatic 
system development, endothelium-derived signals probably mediate the recruitment of 
lymphatic muscle cells to the developing vessel, resulting in the maturation of the 
functional lymphatic. If lymphatic smooth muscle development follows the course of 
the vascular one, the cells generally have a mesodermal origin with local variations 
(116). For example, vascular smooth muscle cells of the great arteries and cardinal veins 
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differentiate from cells of the cardiac neural crest (117). One of the few studies 
documenting lymphatic smooth muscle development has provided evidence that 
lymphatic muscle cells arise from mesenchymal progenitors (118) in this fashion. 
Another possible route for lymphatic smooth muscle development in cardiac lymphatics 
may follow that of the vascular smooth muscle cells of the coronary circulation, where 
they differentiate from proepicardial ones (116; 119). This development route fits with 
the similarities seen in the molecular features of cardiac and lymphatic muscle as well 
as the role of lymphatic muscle in the phasic contractile lymphatic pump. This potential 
route of lymphatic development may also be related to the primitive lymphatic hearts 
that are seen in lower vertebrate species, showing both smooth and striated muscle 
elements (120). 
 
1.5.2 Lymphatic Smooth Muscle intrinsic contractility 
The main function of the lymphatic smooth muscle is to rhythmically contract to allow 
the lymphatics to efficiently propel the lymph, using an unusual array of contractile 
proteins. In fact, these cells express isoforms of myosin heavy chain (MHC) and actin 
which parallel the phenotypic features of vascular, cardiac and visceral myocytes (121). 
The lymphatic smooth muscle contractions are brisk when compared to typical vascular 
smooth muscle ones, with estimated cellular shortening velocities of 2 cell 
lengths/second (101). Yet these same vessels can have long term, tonic changes in 
lymphatic diameter to control flow resistance. Thus lymphatic smooth muscle 
contractions have similarities to both vascular smooth muscle cells and cardiac 
myocytes. In fact, lymphatic smooth muscle cells express different isoforms of myosin 
heavy chain: for example SMB, SM1, and SM2 in rat mesenteric lymphatics and SMA, 
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SMB, SM1 and SM2 in rat thoracic ducts. SM1 and SM2 isoforms differ in their 
carboxy terminus, whereas the SMA and SMB isofroms vary at the region of the ATP 
binding domain of the myosin head (122; 123; 124; 125). Studies have shown that the 
SMB isoform is typically expressed in smooth muscle with faster contractile properties 
and has nearly two times higher ATPase activity than SMA (126; 127; 128). The 
mesenteric lymphatics also express slow-skeletal/fetal cardiac β-MHC, a faster non-
smooth muscle MHC isoform. Because of the strong phasic contractile nature of the 
mesenteric lymphatics, this MHC profile matches the function of the mesenteric 
lymphatics which are stronger pumps than the thoracic duct. In both the thoracic duct 
and mesenteric lymphatics also sarcomeric (cardiac) α-actin and non vascular smooth 
muscle actin proteins are present, demonstrating that lymphatic smooth muscle 
expresses different isoforms of both striated and nonstriated muscle and correlates the 
nature of lymphatic vessels functional similarities to both vascular smooth and cardiac 
muscle cells with the contractile protein isoforms found in these tissues (Fig 1.20). 
These data also explain the regional variations in both functionality and the contractile 




Figure 1.20 Diagrams reporting lymphatic vessel diameter profiles and calcium tracing, and proposed 
regulatory mechanisms for lymphatic smooth muscle. A Changes in vessel diameter due to increased 
pressure or flow. B Example of spontaneous contractions and calcium transients in rat mesenteric 
lymphatic vessel. C and D Lists of both smooth and striated muscle-specific contractile and regulatory 
elements in lymphatic smooth muscle. E The combination of smooth and striated muscle contractile and 
regulatory proteins is involved in modulating tonic and phasic pumping mechanisms. SM smooth muscle, 
MHC myosin heavy chain, MLC myosin light chain, MLCK myosin light chain kinase, MLCP myosin 
light chain phosphatase, TM tropomyosin. Redrawn from (129). 
 
Lymphatic smooth muscle contractions are consequent to action potentials (130) and the 
spontaneous and intrinsic origin of these events suggests that each action potential, or 
group of action potentials, must be preceded by a pacemaker event, evoking the 
transient constriction (131; 132). The action potentials are composed of at least two 
components and, as demonstrated by their sensitivity to blockers of voltage-dependent 
calcium channels, are the consequence of the influx of Ca2+ ions through L-type Ca2+ 
Introduction 
45 
channels (133; 134). They propagate through gap junctions connecting adjacent 
lymphatic smooth muscle cells, as they have been detected in bovine mesenteric 
lymphatic smooth muscle (135). L-type Ca2+ channels are strictly voltage-gated and 
their opening requires the depolarization of lymphatic smooth muscle membrane 
potential, which should be generated by an electrical event (pacemaker potential, Fig 
1.21). Some evidences support these findings: first, studies on large lymphatic vessels, 
such as bovine mesenteric lymphatics, demonstrate that the pacemaker mechanism 
relates to a slow depolarization, leading to the generation of regularly occurring action 
potentials (132), which has been suggested to be due at least in part to the activation of 
an ionic current with properties resembling those of the cardiac pacemaker current (If) 
of sinoatrial nodal cells (136). Moreover, recordings of lymphatic smooth muscle 
membrane potential highlights the existence of small spontaneous transient 
depolarizations, which, either individually or through summation, have been suggested 
to generate action potentials and smooth muscle constriction (137) In fact, the initial 
phase of the spontaneously generated action potential has the same time course as the 
rising phase of spontaneous transient depolarization (137) and also noradrenaline (10 – 
100 nM range) or vessel distention, which both increase lymphatic pumping rate, 
enhance spontaneous transient depolarization activity (137; 138). Furthermore, 
spontaneous transient depolarizations occur independently of both the innervation and 
the endothelium. Therefore, these events are likely to be generated by the smooth 




Figure 1.21 Records of membrane potential and associated constriction of a short segment of lymphatic 
vessel undergoing spontaneous constrictions. A The smooth muscle exhibited spontaneous transient 
depolarizing potentials and action potentials. STDs (Δ) were monophasic and did not cause constriction 
whereas action potentials (▲, ●) were biphasic and induced vessel constriction. B the STD and the action 
potentials marked in A are shown on an expanded time scale. Redrawn from (137). 
 
Thus, in large mammals, such as bovine and sheeps mesenteric lymphatics, the 
pacemaker mechanism leading to the action potential onset is thought to be a slow 
depolarization, due in part to activation of an ionic conductance (136). In guinea-pig 
mesenteric smooth muscle cells, pacemaking seems to be related to spontaneous 
transient depolarizations (STDs), which underlie the rising phase of the action potential 
(130). STDs, also recorded from sheep mesenteric lymphatic smooth muscle are due to 
a calcium-activated chloride (ClCa) current (130; 139), generated by brief release of 
calcium from intracellular stores. If of sufficient amplitude, STDs generate the action 
potential and consequently the contraction (130). Vessel distension and agonists, which 
increase lymphatic pumping, also enhance STD activity, whereas substances that 
decrease lymphatic pumping reduce STD activity (130).  
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Lymphatic smooth muscle is variably innervated in different tissues and species and 
neural activation can have different effects on lymphatic muscle contraction, depending 
upon the nerve type. The lymphatic smooth muscle contractile activity can be 
modulated in an inotropic (change in the contraction strength) and/or chronotropic 
(change in the contraction frequency) fashion by chemical agents like neurotransmitters, 
circulating hormones or substances released by surroundings cells (endothelium, 
immune cells) into the interstitial space, but also by physical factors such as transmural 
pressure, luminal flow and shear stress, which can alter lymphatic tone (Fig 1.22). The 
lymphatic vessels tone can be evaluated as the difference between the systolic and 
completely relaxed (diastolic) lymphatic vessel diameters, expressed as percentage of 
the completely relaxed diameter. The phasic contractile activity is pressure/stretch 
sensitive (101; 140): in fact, increasing in vessel wall stretch induces enhancement both 
in lymphatic contraction frequency and in contraction strength. Particularly, humoral 
substances such as α-adrenergics, β-adrenergics, prostaglandins, bradykinin and 
substance P can also affect both the tone of lymphatics as well as alter the active 
pumping activity. The modulation of lymphatic smooth muscle tone is probably exerted 
by guanylyl cyclase, cyclic GMP, cyclic AMP, protein kinase A, protein kinase G and 
nitric oxide (141; 142; 143; 144; 145; 146; 147; 148). The prevailing hypothesis from 
most studies indicates that numerous factors can inhibit lymphatic contractions through 
the production of cGMP and cAMP, which then lead to the activation of cGMP- and 





Figure 1.22 Mechanism and modulation of lymphatic smooth muscle contractile activity. A Image 
sequence of a pumping lymphatic vessel, showing four chambers contracting in a sequential fashion. In 
(c) for example, chamber 2 which has been filled by chamber 1 contracts and fills chamber 3. The 
unidirectional valve (arrowhead) visible between chambers 2 and 3 is open. In (d), chamber 2 is filled by 
chamber 1, while chamber 3contracts: the valve is now closed to prevent lymph backflow (scale bar 100 
μm). B Schematic illustration of hypothesis for lymphatic smooth muscle contraction. C Schematic 
illustration of the flow induced modulation and the structures involved in pumping activity modulation. D 
Mechanisms and signaling pathways involved in lymphatic pumping activation/inhibition. Redrawn from 
(50).  
 
Transmural pressure (eq. 1.1 and 1.2) may itself be considered an important lymphatic 
pumping modulatory agent, which alters both strength and frequency of lymphatic 
contractions. Some studies, performed both in vivo and in vitro, report that an increased 
transmural pressure causes positive inotropic and chronotropic effects on lymphatic 
vessels pumping activity; obviously, lymphatics from different tissues and species have 
different hydrostatic pressures at which they reach their maximum pumping activity, but 
increasing lymph pressure beyond these values results in diminished pumping (101; 
105; 149; 150; 151; 152; 153). On the other hand in bovine mesenteric lymphatics it has 
been demonstrated that there is little or no correlation between lymphatic vessels 
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contractions and distension/stretch stimuli (154). Moreover, isolated bovine and rat 
mesenteric lymphatic vessels show stable spontaneous pumping activity even when held 
at an intraluminal pressure of zero cmH2O and in the absence of either radial or axial 
distension, leading to the conclusion that lymphatic vessel wall distension by 
intraluminal pressure is a key factor which is able to modulate the lymphatic pumping 
activity, but it is not a mandatory factor for pacemaking. 
Lymph flow usually shows not only great changes in magnitude, but also transient 
changes in its direction. Thus, if lymphatic active pumping activity is sensitive to the 
shear stress exerted by lymph flow, also lymph flow itself is not only generated by the 
lymphatic pump but can provide a feedback, even influencing the pump activity. In fact, 
in isolated bovine mesenteric lymphatics an inhibition of both amplitude and 
contraction frequency (Fig 1.23), due to the controlled increase in imposed flow has 
been found (155). Moreover in isolated mesenteric lymphatics or thoracic duct from the 
rat the imposed-flow caused the inhibition of the active lymphatic pumping activity 
(148). The active pump of the thoracic duct appears much more sensitive to flow than 
the mesenteric lymphatic one (156): imposed-flow decreases both the frequency and 
amplitude of contraction and consequently the lymphatic flow itself is reduced. The 
flow-induced inhibition of lymphatic pump causes a rapidly developing inhibition of 
contraction frequency, dependent on the magnitude of imposed flow but not on its 
direction, and a slowly developing inhibition of the amplitude of the lymphatic 




Figure 1.23 Effect of imposed flow on the active pumping activity in rat mesenteric lymphatic vessels. A 
Input and output pressures are 5 cm H2O, and imposed flow gradient is 0 cm H2O. B Input pressure is 8.5 
cm H2O, output pressure is 1.5 cm H2O and imposed flow gradient is 7 cm H2O. The increased imposed 
flow decreases the contraction frequency and increases the systolic diameter length. Redrawn from (148). 
 
1.5.3 Pharmacological modulation of intrinsic lymphatic function 
The release of inflammatory mediators is thought to increase vascular permeability, 
leading to possible edema formation. Once in the inflamed tissue environment, 
inflammatory mediators and cells producing them can enter initial lymphatic vessels, to 
reach the lymph nodes. Following this path, inflammatory mediators can potentially 
play an additional role in altering lymphatic vessel contractility and hence lymph flow. 
Due to the multi-target action of inflammatory mediators, it is difficult to determine 
whether lymphatic phasic pumping activity is affected by the edema-mediated filling of 
the vessel and subsequent constriction and/or directly by the inflammatory mediators 
themselves. Systemic administration of histamine has been shown to induce a 
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significant increase in lymph flow (157; 158; 159), which seems to be due to the 
histamine-induced increase in transvascular efflux of fluid and protein, at the level of 
the transcapillary venule (158; 160). Pre-treatment with a H1-antagonist suppresses the 
histamine-induced increase in lymph flow and protein concentration, suggesting that the 
increase in lymph flow caused by stimulation of H1-receptors can be affected by the 
increase in lymph formation (161). On the other hand, histamine decreases lymph flow 
when delivered to the thoracic duct of dog through the vasa vasorum (151). Topical 
application of histamine on mesenteric lymphatic vessels of anaesthetized rats causes an 
increasing in vessel diameter length and contractility, while contraction frequency is 
unaffected (162). Because histamine is also present in the interstitium during 
inflammation and has been detected in lymph drained from injured tissues, it is 
conceivable that histamine directly stimulates lymphatic vessels function (163). 
The effect of serotonin (5-HT) on lymphatic vessels pumping activity has been 
investigated in isolated longitudinal bovine mesenteric lymphatic segments, where it 
evokes tonic contractions (164). The effect of serotonin on lymphatic vessels contractile 
activity has also been described in canine thoracic duct and in porcine tracheobronchial 
and hepatic vessels (165; 166; 167). However, when vessels are pre-constricted, it has 
been reported that serotonin causes a vessel relaxation (168). Pharmacological 
characterization of the receptor subtypes revealed that vessel contractions are mediated 
by 5-HT2 receptors, whereas 5-HT4 receptors mediate the vessel relaxation, both 
receptor types being located on the smooth muscle (168). In spontaneously contracting 
sheep mesenteric vessels, serotonin primarily causes an inhibition of the spontaneous 
constriction; an increase in contraction frequency has been observed only when the 
inhibition has been blocked by the 5-HT4 inhibitor DAU 6285 (169; 170). 
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Acetylcholine administration to lymphatic vessels shows a relaxation of pre-constricted 
thoracic duct and tracheobronchial lymphatics in dogs and induces a slowing of 
spontaneous transient contraction in bovine, porcine and guinea-pig mesenteric 
lymphatics and in afferent lymph microvessels from iliac lymph nodes in rats (141; 143; 
171; 172; 173; 174). These effects have been shown to be mediated, at least in part, by 
the endothelial release of nitric oxide, because nitric oxide-donors mimick the 
acetylcholine-induced response. Moreover, nitric oxide-synthase (NOS) inhibitors 
slightly affect lymphatic phasic contractility, as reported in isolated mesenteric 
lymphatic vessels. Thus, the physiological role of the lymphatic endothelium in the 
regulation of spontaneous lymphatic pumping activity involves the endogenous 
production of nitric oxide by the constitutive endothelial nitric oxide synthase (eNOS), 
which for example decreases the lymphatic pumping activity in the rat mesentery (175). 
Moreover, during inflammation, also macrophages produce nitric oxide (176). The 
result of nitric oxide-mediated effects is an inhibition of lymphatic function and 
consequently result in a facilitation of the edema formation. 
Arachidonic acid products are amongst the most important modulatory molecules of 
inflammation acting, as they are non-steroidal anti-inflammatory drugs, at least in part 
by inhibiting prostaglandin synthesis. Studies in which the effects of inhibitors of cyclo-
oxygenase and other arachidonate metabolism pathways on lymphatic vessels have been 
investigated show that the spontaneous pumping activity is suppressed in their presence 
(177; 178), suggesting the ability of lymphatic vessels to generate arachidonate products 
in order  to modulate their spontaneous activity. Moreover, non-contracting lymphatic 
vessels can be induced to rhythmically contract with a variety of derivatives, the most 
potent being the stable receptors for prostaglandin H2 and thromboxane A2 
(PGH2/TXA2) mimetic (compound U46619), and the leukotrienes B4, C4 and D4. 
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Arachidonic acid by itself induces a variety of contractile responses in bovine 
mesenteric lymphatics, this probably due to the fact that it may be converted by the 
lymphatic vessel to stimulatory and inhibitory metabolites.  
In guinea-pig mesenteric lymphatics, substance P and ATP enhance contraction 
frequency. These responses are prevented by the cyclo-oxygenase inhibitor, 
indometacin, the TXA2 synthase inhibitor, imidazole and the PGH2/TXA2 receptor 
antagonist, SQ29548, suggesting that substance P and ATP both induce the endothelium 
to release the prostanoid PGH2/TXA2, which serves as a diffusible activator (179; 180). 
Indometacin or SQ29548 have also been shown to inhibit the perfusion-induced vessel 
constriction and increase the vasomotion frequency in microlymphatics of rat iliac 
lymph node with an intact endothelium, further suggesting that the lymphatic 
endothelium is able to release the constrictor prostanoid PGH2/TXA2 in response to an 
increase in intraluminal flow (174).  
Cyclo-oxygenase (COX) metabolites and prostaglandins have been extensively 
demonstrated to directly affect lymphatic pumping and induce powerful excitatory and 
inhibitory responses on isolated mesenteric lymphatic vessels (147; 181; 182). The 
source of COX metabolites was proposed to be the endothelium because lymphatics 
with an intact endothelium are able to release the dilator prostaglandins PGE2 and/or 
prostacyclin when stimulated by PAR-2 activation (183) or arachidonic acid (174) or 
the constrictor prostanoid TXA2 in response to increase in intraluminal flow (174) and 
stimulation with substance P (179), suggesting that lymphatic production of 
prostaglandins should be altered during inflammation. 
Bradykinin increases lymphatic vessels contraction frequency and lymph flow, in a 
dose-dependent manner, but it does not affect the spontaneously pumping lymphatic 
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vessels tone. In fact a B1 antagonist (Des-Arg9-[Leu8]-bradykinin) has no effect on the 
baseline of lymphatic pumping but completely inhibits the bradykinin-induced increase 
in contraction frequency; on the contrary a B2 antagonist (N-acetyl-D-Arg-
[Hyp3,Thi5,8,D-Phe7] bradykinin) significantly depresses lymphatic contraction 
frequency in baseline conditions but shows no effect on bradykinin-induced increasing 
in contraction frequency, suggesting that bradykinin induces positive chronotropic but 
not inotropic effects on lymphatic pumping activity through the stimulation of B1 
receptors (184). 
Heparin is one of the major endogenous substances with potent anticoagulant activity 
and is extensively used in medical practice. In fact, as a natural anticoagulant heparin is 
used for the prevention and therapy of thromboses. It’s anticoagulant activity is 
associated with the activation of antithrombin, contributing to the decrease in platelet 
adhesion and aggregation. Heparin has a strong relaxing effect on lymphatic smooth 
muscle, decreasing both amplitude and frequency of spontaneous phasic contractions. 
Also the tone of lymphatic smooth muscle decreases after heparin exposition: it has 
been reported that the inhibitory effect of heparin on lymphatic smooth muscle is 
mainly endothelium-dependent, by constitutive NO synthase activation (185). 
The alpha receptor antagonists prazosin (alpha 1) and yohimbine (alpha 2) not 
significantly alters lymphatic vessels tone or contractile activity in mesenteric 
lymphatics, suggesting that lymphatics do not possess basal adrenergic tone. On the 
other hand, norepinephrine and phenylephrine administration produce dose-dependent 
effects both in increasing contraction frequency (and consequently lymphatic flow) and 
in decreasing diastolic diameter length. The changes in lymphatic pumping activity 
induced by norepinephrine is completely blocked by prazosin or phentolamine and only 
partially by yohimbine, whereas the alpha2-adrenoceptor agonist (alpha-methyl-
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norepinephrine) induces no changes in lymphatic function, supporting the hypothesis of 
the existence of alpha-adrenoceptors on lymphatic smooth muscle. Thus conditions 
characterized by increased sympathetic outflow may increment lymphatic function 




1.6 Lymphatic safety factors  
Interstitial pressure affects the transmural pressure gradient driving lymph formation. 
The potential of the initial lymphatic lumen to collapse under a positive pressure 
difference is minimized by their unique anatomy, as initial lymphatics endothelial cells 
are tethered to the interstitium by anchoring filaments (40) responsible for holding the 
lumen open during conditions of increased tissue pressure or swelling, creating large 
(~2 μm diameter) interendothelial non selective pores. Those pores are a consequence of 
the “button”-like pattern of endothelial cell-cell junctions, in contrast to the contiguous 
expression of these molecules in blood vessels and collecting lymphatics endothelium 
(187). Therefore, interstitial fluid is able to access the initial lymphatic lumen especially 
during edematous states when tissue pressure becomes positive.  
Possibly as a result of direct communication between interstitial fluid and lymphatic 
lumen, interstitial pressure and lymph flow are positively related (188). In dog hind leg, 
the rise of lymph flow is quickest at tissue pressures of ~0 − 1 cmH2O and attains a 
sustained maximal value when tissue pressure reaches 2 cmH2O. The relevance of this 
relationship is that it maintains a constant interstitial fluid volume due to the tight 
correlation between interstitial volume and interstitial pressure shown in Fig 1.26 B 
(189). Two edema safety factors are evident from Fig 1.26, assuming that interstitial 
pressure is normally negative: a) since interstitial pressure must rise above 2 cmH2O to 
lead lymph flow to plateau, large changes in interstitial pressure can be accommodated 
before edema develops, and b) an elevated lymph flow will quickly return the interstitial 
volume back to the normal value, as long as the excess fluid volume does not exceed the 
capacity of the lymphatic circulation. Thus, a small increase in interstitial fluid volume 
significantly increases its hydrostatic pressure, promoting lymph flow which acts 




Figure 1.24 Relationship between lymph flow and interstitial fluid pressure. A shows the relative 
increase in lymph flow in response to changes in tissue hydrostatic pressure (PT, mmHg) during 
edematous conditions induced by intravascular infusion of Ringer’s. B shows interstitial fluid volume 
(IFV, L) in response to changes in tissue hydrostatic pressure. Redrawn from (190). 
 
In fact, during the rapidly rising phase of interstitial fluid pressure reported in Fig 1.24 
A, lymphatic vessels becomes progressively more filled, thereby stretching their vessel 
walls and also increasing lymphatic pumping activity. However, when interstitial fluid 
pressure reaches the atmospheric value interstitial fluid begins to compress the outer 
lymphatics wall, preventing a further increase in lymph flow, thus explaining the 
plateau phase. Therefore, a great increase in lymph flow mainly occurs in negative to 




1.7 Pathologies associated to the Lymphatic System 
Malfunction of the lymphatic vasculature can result in congenital or acquired disorders 
such as edema, which is a disfiguring and disabling disorder often characterized by 
swelling of the extremities, tissue fibrosis, accumulation of subcutaneous fat, and 
susceptibility to infections (191; 192). Impairment of lymphatic drainage caused by 
dysfunction of the lymphatic vasculature leads to fluid and solutes accumulation into 
the interstitial space, and eventually to lymphedema, a chronic progressive swelling of 
the affected tissues (Fig 1.25). Lymphedema can be either hereditary (primary 
lymphedema) or a consequence of a disease, trauma, surgery, or radiotherapy 
(secondary or acquired lymphedema).  
 
Figure 1.25 Pathologies associated to the lymphatic vasculature failure. Different alterations in the 
lymphatic vascular network can lead to a variety of pathologies: hypoplastic, hyperplastic, leaky or 





Lymphedema is also a disabling and disfiguring condition severely affecting the quality 
of life and at the moment and no cure exists: traditional supporting management of this 
disease includes manual lymphatic drainage, massage, and external compression. In the 
past few years the growth of new functional lymphatic vessels has been successfully 
induced in a mouse model of lymphedema as well as in healing diabetic and surgical 
wounds  (194; 195; 196). The VEGFR-3-specific mutant form of VEGF-C, VEGF-
C156S, is effective in stimulating the growth of lymphatic vessels without having effects 
on blood vascular vessels, such as increase of leakiness caused by wild-type VEGF-C, 
which also activates VEGFR-2 (197). 
 
Figure 1.26 Lymphedema. Failure in lymphatic vascular function can be caused by various 
developmental or acquired structural defects. Hereditary or primary lymphedema can be caused either by 
total absence or severe reduction of lymphatic vessels or by abnormal lymphatic vessel morphology. 
Secondary or acquired lymphedema is usually due to disruption or trauma of lymphatic vessels by injury, 




Primary lymphedemas (Fig 1.26) are estimated to affect approximately 1 in 6000 
people, with a sex ratio of approximately one male to three females. Hereditary 
lymphedema type I (Milroy's disease) is an early-onset form of lymphedema, which 
becomes apparent at birth affecting primarily legs and feet: in these patients the 
lymphatic vessels are absent or extremely hypoplastic in the affected areas, but not in 
the unaffected ones (198). Hereditary lymphedema type II (Meige disease) is a late-
onset form of primary lymphedema, commonly detected around puberty. Studies on its 
inheritance has linked this disease to an inactivating mutation in the FOXC2 gene (the 
transcription factor Forkhead box protein C2, (199)). In general, both these diseases are 
characterized by dilated lymphatic vessels and accumulation of lymph fluid. 
Lymphedema-distichiasis syndrome is a multisymptoms disorder characterized by 
edema of the limbs, with pubertal or variable age of onset, associated with a variety of 
congenital abnormalities. In several families with this pathology, inheritance has been 
linked to mutations in the FOXC2 gene (200). 
In the thorax primary lymphedema may lead to both chronic pulmonary interstitial 
edema (201; 202) and pleural effusion. An increase in pulmonary interstitial fluid 
volume impairs the diffusion of respiratory gases at the alveolus-capillary membrane, 
while an increased pleural fluid volume and pressure strongly reduces lung expansion, 
both these events severely impairing respiratory function. 
 
Secondary lymphedema (Fig 1.26) may develop in upper or lower extremities or in 
external genitals as a consequence of invasive surgeries, radiation or traumas and 
represents the primary form of lymphedema in industrialized countries. Its incidence, 
approximately 6 % to 30 % of operated patients, is increased by radiotherapy but its 
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etiology and pathophysiology are still not fully understood and appears to be 
multifactorial (191). Worldwide, the most common cause of lymphedema is filariasis, 
currently affecting over 120 million people, mostly in tropical areas. It is caused by 
mosquito-transmitted infection with the parasitic nematodes Wuchereria bancrofti, 
Brugia malayi, or Brugia timori. These parasites live and reproduce in the lymphatic 
system, causing a massive dilation of lymphatic vessels and eventually a complete and 
permanent disruption of lymphatic transport, which leads to a predisposition to long-
term recurrent bacterial infections and a condition known as elephantiasis (203).  
Common complications of lymphedema include progressive dermal fibrosis, 
accumulation of adipose and connective tissue, impaired wound healing, decreased 
immune defense and thus increased susceptibility to infections (191). In rare cases, 













Lymph formation and propulsion are mainly driven by hydraulic pressure gradients 
developing between the interstitium and the initial lymphatic vessels lumen, or between 
adjacent lymphangions, which represent the functional units of the lymphatic system. 
Lymphatic vessels immersed in highly moving tissues such as the diaphragm, which is 
the experimental model of this study, or more generally all thoracic tissues, undergo 
cyclic displacement which consist of compression and expansion of the vessels lumen 
imposed by local stresses resulting as a consequence of cardiac and respiratory 
activities. Therefore, historically most of the forces affecting diaphragmatic lymphatics 
function have been considered to be generated by extrinsic pumps. On the other hand, 
some recent evidences underlined that passive pressure gradients measured in vivo are 
not always able to correctly predict the lymph flow direction in lymphatic loop 
structures, suggesting the existence of at least another kind of force affecting lymph 
flow. However, although the intrinsic and extrinsic mechanisms are recognized as 
important factors in the formation and propulsion of the lymph from the tissues to the 
vascular venous stream along the lymphangions chain, the intimate integration of 
factors leading to accurate modulation of the lymphatic flow to cope with the 
requirements of each tissue are at present far from being clarified. Indeed, a combined 
study of the simultaneous effects of spontaneous lymphangion contraction and tissue 
motion under physiological condition in normal tissues has not been performed yet due 
to the difficulties of the experimental approach.  
To fill in this gap of knowledge on the function of initial lymphatic, we developed a 
series of targeted studies to try to characterize the mechanical behavior of initial 
lymphatic and the specific role of the intrinsic and the extrinsic mechanism in fluid 





1. to verify, and eventually characterize, the intrinsic contractility, never accurately 
investigated before, of the initial diaphragmatic lymphatics and its ability to generate 
lymph flow 
2.  to locally and in a controlled manner modify the extracellular tissue stress and 
displacement to verify its effect on the development of transmural pressure gradients. 
In analogy with the cardiac mechanics the contractile cycle of lymphatics can be 
divided into periods of lymphatic systole and diastole (204; 205). The determination of 
mechanical parameters such as contraction frequency, stroke or compliance volumes, 
ejection fraction and lymph flow has been used to evaluate the extent and role of 










3. Materials and Methods 
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Part I 
3.1 In vivo experiments 
The experiments of this study were performed on the pleural submesothelial 
diaphragmatic lymphatic network of adult Wistar rats (mean body weight: 327 ± 33 g,  
n = 11) which were housed and handled following the guidelines of the University of 
Insubria ethical research committee. Rats were anaesthetised with an intraperitoneal 
injection of 75 mg/kg ketamine (Sigma Aldrich, Milan, Italy) and 0.5 mg/kg 
medetomidine (Domitor, Pfizer) cocktail. Half-boluses of the same anesthetic cocktail 
were administered every hour until the end of the experiments, when animals were 
euthanized via an anesthesia overdose. The maintenance of a deep surgical anesthesia 
level was assessed on the basis of the lack of the hind-paw avoidance reflex. 
Once deeply anesthetized, rats were turned supine on a warmed (37°C) blanket and 
were tracheotomised, inserting a T-shaped cannula into the trachea: this surgical 
procedure was performed using a T-cannula in order to alternatively connect the animal 
to the mechanical ventilator or the continuous oxygen line. Afterwards, the 
diaphragmatic lymphatic network was in vivo stained by an intraperitoneal injection 
(Fig 3.1) of 2% FITC-dextran conjugate (FD250S – Sigma Aldrich) in saline plus 10% 
microspheres (F8813 – FluoSpheres® Carboxylate-Modified Microspheres, 0.1 µm, 
Yellow-Green Fluorescent (505/515)) which provides a stable long-term labeling of 
diaphragmatic lymphatics. The injecting cannula was inserted through the lateral wall of 
the abdomen and it was driven along the cranial surface of the liver in order to correctly 
position the tip in the subdiaphragmatic medial region. To facilitate the right cannula 
allocation and not to scratch the peritoneal surface of the diaphragm, the cannula tip was 
shaped to adapt to the diaphragmatic dome curvature. 
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Figure 3.1 FITC-conjugated dye drainage from peritoneal cavity (PC). Subperitoneal lymphatics vessels 
(darker vessels) are extremely flat (arrowheads) for the most part and drain lymph fluid from the 
peritoneal cavity through the stomata (S). Lymphatics immersed in muscle fibers (M) are connected to 
some subpleural ones (lighter vessels), allowing their FITC-filling. Arrows indicate FITC-dextran path in 
the diaphragmatic lymphatic system. PLC, pleural cavity. From (80). 
 
After 1 hour of in vivo staining in the prone position, the animals were turned supine 
again, the jugular vein and carotid artery were exposed. a PE60 plastic saline-filled 
catheter was inserted in the right carotid artery and connected to physiological pressure 
transducers (Model P23XL, Gould Electronics) in order to monitor arterial pressure and 
heart rate. Animals were paralyzed with a single bolus of 0.3 ml pancuronium bromide 
(Sigma Aldrich) solution (2 mg/ml in saline) administered in the jugular vein. 
Immediately after paralysis, the tracheal cannula was connected to a mechanical 
ventilator (Harvard Apparatus, model Inspira ASV DC1-7058, USA) and rats were 
ventilated in room air at a tidal volume and frequency automatically set by the ventilator 
on the basis of rat weight. The mechanical ventilation is required for the chest wall 
opening: in fact, when pleural pressure becomes atmospheric lung inflation needs to be 
supported by positive end-inspiratory alveolar pressure. Subsequently the chest wall 
was opened by mid-sternal thoracotomy and the four to five most caudal ribs were 
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removed in order to expose the right pleural diaphragmatic dome, taking care to not 
pierce the diaphragmatic surface, and dehydration was prevented by frequently rinsing 
with a gentle flush of warm saline solution (37°C). 
The pleural submesothelial lymphatic mesh was visualized under a stereomicroscope 
equipped with a black-and-white CCD camera (ORCA ER, Hamamatsu, Milan, Italy) 
connected to a personal computer running SimplePCI software (Hamamatsu). 
Lymphatic vessels filled with FITC-dextran were identified due to the FITC excitation 
with an optic fiber epi-illuminator equipped with a 425 ± 65-nm bandpass filter (Carl 
Zeiss Italy) and fluorescence emission was collected by the stereomicroscope fitted with 
a two-bandpass filter (FITC/TRITC, catalog no. 56918, Chroma Technology, 
Rockingham, VT). Images were collected at 1 – 10 Hz to optimize the spatial and 
temporal resolution of the contracting vessels kinetic and lymph flow. The exposure 
time was routinely set to 0.2 s or lower. During the recording periods, rats were 
temporarily disconnected from the ventilator and oxygenated with a continuous intra-
tracheal flux of 50% O2 in nitrogen at a continuous positive airway pressure of 7 
mmHg, in order to minimize the field oscillations due to the ventilator-supported 
inflation/deflation lung displacement. 
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3.2 Whole mount assay 
The most commonly used techniques for vessels imaging are (a) immunolabeling of 
endothelial cell using specific markers, (b) intravital perfusion of a not specific label, 
and (c) casting of the network by intravascular injection of a filling agent, followed by 
corrosion of the surrounding tissue for imaging by scanning electron microscopy 
(SEM). In this case we used the three-dimensional stacks of vessels images, which 
revealed the detailed architecture of the microvascular network. The presence of smooth 
muscle elements in the vessel wall of diaphragmatic lymphatics was assessed by whole 
mount immunofluorescence assay. Therefore, after contracting vessels were in vivo 
video recorded for further offline analysis, the diaphragm was fixed in situ for ten 
minutes with 4% Paraformaldehyde (PFA, Sigma Aldrich), immediately after the 
animal had been suppressed. Then specimens were excised and post-fixed for twenty 
minutes with 4% PFA; they were then rinsed in Phosphate buffered saline (PBS, Euro 
Clone) three times for five minutes each and subsequently permeabilised in ice cold 
100% methanol and 0.5% Triton X-100 (Sigma Aldrich) in PBS. Diaphragmatic tissue 
samples were rinsed with PBS three times, five minutes each and then incubated in 
blocking solution (1% bovine serum albumin ,BSA, , and 5% goat serum in PBS) for 
one hour in order to saturate nonspecific binding sites. Specimens were then cut into 
two pieces: one section was incubated overnight with primary mouse anti α-smooth 
muscle actin antibody (1:25 – Actin Alpha 2 Smooth Muscle Antibody (1A4) – Novus 
Biologicals) in blocking solution at 4°C. The second section was incubated for the same 
amount of time in blocking solution, at 4°C. Both sections were then rinsed three times 
with PBS for five minutes each, followed by an incubation with the secondary goat anti-
mouse antibody conjugated to Alexa Fluor® 647 (1:100 – goat anti-mouse IgG2a – 
Molecular Probes) for one hour at room temperature. The diaphragmatic specimens 
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were finally washed three times with PBS for five minutes each and then mounted onto 
a coverslip glass with Fluoroshield (F6057, Sigma Aldrich) for confocal microscope 
(Leica TCS SP5, Germany) observation. 
Laser scanning confocal microscopy permits to collect high resolution digital images 
from a series of optical sections through the whole thickness of the sample. 
Epifluorescence microscopy is widely used in vascular imaging, but excitation and 
emission light scattering usually limits the depth to which high-resolution images can be 
collected to < 40 μm and further error may be introduced as 3D structures are projected 
onto a 2D plane (208). Confocal microscopy, which reduces out of focus light via a 
pinhole, can image to greater depths and is routinely used to collect 3D image data. 
Stained vessels were confocally scanned throughout the entire diaphragmatic depth in 
0.5-μm z-axis steps, using a 20X dry objective and a pinhole corresponding to one Airy 
Unit. The negative controls for all experiments were produced and analyzed via similar 
procedures, except that the control samples were not incubated with primary antibody 
(see above). In addition, aorta specimens were processed as illustrated above and used 
as positive controls. Negative and positive controls were scanned with the same 
instrument settings as the specimens for a valid comparison of relative fluorescence 
intensities. Photobleaching, the loss of the fluorescent signal due to the exposure to the 
laser light, was not prominent during scanning. 
The analysis of confocal images was performed using Image J (MBF package, version 
1.46j – http://rsbweb.nih.gov/ij/; http://www.macbiophotonics.ca/imagej/) and Adobe 
Photoshop software. Pleural diaphragmatic lymphatic network overviews were obtained 
in silico by aligning and superimposing consecutive images into a continuous panorama 
using Adobe Photoshop software. Serial sections were recorded beginning at the top 
surface of the specimen (placed pleural side up) and the resultant stacks of individual 
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lymphatic vessels and intraluminal valves were rendered in three dimensions using 3D 
projection function with brightest point projection and a complete rotation around the y 
axis method of Image J. Lymphatics cross sections were obtained using Reslice function 
of Image J software on the previously merged z-stacks. 
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3.3 Offline analysis 
3.3.1 Diameter vs time profiles 
Measuring diameter length is a standard technique in vascular research. Initially light 
microscopy with graded eyepieces was used, and then video microscopy allowed taping 
and analysis in time (209; 210). Later, multi-sites simultaneous measures were 
performed on digital images, both online and offline (211; 212). Eventually, automatic 
measures of diameter profile at sites of interest was reported for many medical 
applications, including coronary angiography, b-mode ultrasound, CT and MRI data 
(213; 214; 215; 216).The vessel diameter of a structure can also be determined 
manually, which is extremely time-consuming and allows only a small number of 
images to be processed. In fact, the human observer, although excellent in pattern 
recognition, has further deficits which give rise to reduced reproducibility (217). 
Video in vivo recorded were transformed from the Simple PCI proprietary *.cxd format 
to a multipage TIFF stack and then the open source package ImageJ (NIH) was used for 
offline image analysis. The “Diameter” (218) plug-in uses an algorithm to estimate the 
inner diameter, based on the FITC-fluorescent dye filling the vessel (Fig 3.2): the 
contrast of the lymphatic vessel is produced by the FITC-conjugate emission, which 
results in a homogenous light structure in front of a dark background. 
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Figure 3.2 Image J’s Diameter Plugin. Panel A shows Diameter plug-in algorithm intermediates, which 
estimates boundary (a – maximum intensity changes), reference intensities (b) in the three resulting areas, 
threshold (c – mean of adjacent reference intensities) and finally vessel boundary (d ), where the linear 
trend around the boundary estimates crosses the threshold (circles represent the raw data used for 
calculation). The bottom panels demonstrate the concordance of manual and automatic measurements at 
the same position: The product-momentum correlation is R2 = 0.991, and results can be fitted by a linear 
trend (B).The ratios of automated/manual results are provided in a histogram (mean 1.004, C). Modified 
from (218). 
 
In detail, the algorithm requires a line selection, which has to cross the vessel and to 
exceed the maximum vessel diameter during the recorded period on both sides. This is 
why ROI were plotted on the z-stack maximum projection image. The “Dynamic 
Profiler” function of ImageJ showed the pixel intensities profile along the selected line 
in real time. The estimate borders (a1 and a2 in Fig. 3.2) are the two positions with the 
maximum difference between the mean intensity of the three adjacent points to both 
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3.2) are the darkest areas outside the blood vessel, separately for both sides, and the 
brightest area within the vessel, determined by the average of three consecutive points. 
The intensity threshold (c1 and c2 in Fig. 3.2) is the average of the adjacent reference 
intensities, calculated separately for both sides to account for different surroundings of 
the vessel. The intensities of the two positions left and right of the border estimates are 
fitted with a linear trend. The points of intersection (d1, d2 in Fig. 3.2) of the fit with the 
intensity threshold give the precise vessel edges. Half of maximal vessel thickness 
correspond to sqrt (3/4) of the radius; therefore the diameter length of the vessels is 
[d1,d2] * sqrt (4/3). The diameter and both ends of the full width at half-maximum of the 
vessel (in pixels, then transformed in µm) of the five adjacent measurements and for 
every loaded ROI were eventually copied to the system clipboard and subsequently 
analysed with Origin 5.0 software. 
 
3.3.2 Fluorescence vs time profiles 
Fluorescence intensity profiles were obtained by Image J multi-measure function on a 
single ROI placed within the vessel borders (ROI were placed on the minimum intensity 
projection in order to avoid possible artifacts). Then results were copied on an Origin 
5.0 worksheet an plotted vs time. 
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3.3.3 Data analysis 
The contractile cycle of lymphatic vessel can be divided into periods of lymphatic 
systole and diastole (Fig 3.3), in close analogy with the cardiac cycle. Contraction 
frequency, stroke volume, ejection fraction and lymph flow can be determined to 
evaluate lymphatic pumping function by means of this cardiac analogy (101; 205). 
 
Figure 3.3 Typical diameter vs time profiles of lymphatic vessels showing active (continuous line), 
hybrid (dashed line) or passive (dotted line) mechanical behavior throughout the intrinsic lymphatic 
contraction cycle Details of their behavior are illustrated below in the “Results” section. Lymphatic 
pumping parameters are defined in a fashion similar to the cardiac cycle. Diastolic diameter (*, μm); 
systolic diameter (arrows, μm); fully expanded diameter (arrowheads, µm); pumping frequency (F) = 
contractions/minute or expansion/minute; stroke volume (SV) = diastolic volume (or peak volume) − 
systolic volume; ejection fraction (EF) = SV (or CV)/diastolic volume; lymph flow (LF) = SV (or CV) × 
F. 
 
The mean value of five diameter measurements was transformed to the corresponding 
microns value and then plotted vs time using Origin 5.0 Software, taking care to 
exclude data causing SD >2 pixels. Table of results was then copied to a Clampfit 10.2 
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Systolic and fully expanded diameters were obtained by manually placing cursors at the 
lowest/highest value in the plot profile of the cyclical pumping activity (for 1 Hz 
profiles) or as the mean value of 0.5 seconds sampling  interval (for 10 Hz profiles), to 
reduce the higher noise proper of this kind of traces. Also diastolic diameter length was 
measured as the mean value of at least five seconds sampling interval recorded as a 
stable trace reaching plateau, immediately before the next downward/upward deflection, 
both for pumping vessels or not contracting ones, in order to be subsequently compared.  
Cyclic active contraction or passive expansion period (sec) was estimated using 
Autocorrelation function of Clampfit 10.2 Software. The Autocorrelation function (Fig 
3.4 A)provides time series analysis, looking for cycles within data: traces are shifted 
along themselves incrementally (in "lags") and the output is an "autocorrelation function 
estimate" (ACFE) calculated at each lag point, measuring the match between the static 
and shifted sets: the time period corresponds to the highest ACFE lag. The pumping 
frequency (F) was then calculated as the period reciprocal value (Hz) and transformed 
in bpm by multiplying by 60. 
Cross-correlation (Fig 3.4 B-D) between traces simultaneously recorded in different 
tracts of the same lymphatic network was performed by Cross-correlation function of 
Clampfit 10.2 Software. Also the Cross correlation function provides time series 
analysis, looking for regularities between two data sets: the first data set is shifted along 
the second one incrementally (in "lags"), in both directions, and the output is a "cross-
correlation function estimate" (CCFE) calculated at each point, measuring the match 
between the two sets. Positive peaks (0 < CCFE < 1) indicate that the two waveforms 
are in phase, whereas negative peaks (-1 < CCFE < 0) indicate that they are out of 
phase; CCFE = 1 corresponds to complete identity between the two traces. 
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Cross-correlation differs from autocorrelation in that two or more data sets are 
compared with each other, and not with themselves. 
 
Figure 3.4 Examples of autocorrelation (A) and positive (B) or negative (D) cross-correlation plotted 
profiles. In C is reported the CCFE plot of two uncorrelated traces. 
 
Lag period calculated with cross-correlation analysis was also used to calculate spread 
velocity (µm/sec) of contraction in active pumping vessels as indicated in eq. 3.1: 
	 = 	 ∆     (3.1)   
where Δlenght (µm) is the distance between two adjacent actively pumping sites with no 
zero lag (sec). 
The time constant, denoted by the Greek letter τ (tau), is the rise time characterizing the 
passive relaxation after lymphatic vessel constriction. The constant represents the time 
(sec) the vessel takes to reach 1-1/e ≈ approx 63.2% of its diastolic value: the larger the 
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(Fig 3.5) was found by fitting a single exponential function (eq. 3.2) to the acquire data 
using Clampfit 10.2 Software Fit Function, on a previously low-pass filtered diameter 
profile, using the exponential standard method (number of terms = 1): 
( ) = 	 ∑ / + 	     (3.2)   
where A is the initial diameter length, t is time and C is an arbitrary vertical offset. 
 
Figure 3.5 Example of tau exponential fitting performed using Fit function of Clampfit 10.2 Software. 
 
The relationship between amplitude and frequency of contractions in actively pumping 
vessels was fitted by Sigma Plot 10.0 by Dynamic Fit Wizard as a rectangular hyperbola 
(eq. 3.3): 
= + ∙      (3.3)   
The stroke volume (SV) indicates the volume of lymph (expressed in pL) pumped by an 
active or hybrid vessel at each contraction. SV is calculated using mean values of 
systolic and diastolic diameter lengths at each analyzed site over the full trace. Based on 
previous evidences which revealed that the cross-sectional area of diaphragmatic 
superficial lymphatics tends to be elliptical rather than cylindrical and the smaller radius 















Materials and Methods 
79 
was estimated for a lymphatic segment of 10 µm length as [(diastolic cross-section – 
systolic cross-section) * 10 µm] 
= 	 2
∙ 2 ∙ 0.35 ∙ − 2 ∙ 2 ∙ 0.35 ∙ ∙ 10
10  
where dD (µm) and dS (µm) are diastolic (peak value for hybrid vessels) and systolic 
diameters respectively, 0.35 is the smaller transverse to the larger in the plane radius 
ratio and 103 is the µm3/pl conversion factor. 
Similarly the diastolic volume load (DVL) indicates the volume of lymph (expressed in 
pL) accumulated into a lymphatic segment during the diastolic phase. DVL is calculated 
using mean values of fully expanded and diastolic diameters at each analyzed site over 
the full trace. DVL was also estimated for a lymphatic segment of 10 µm length as 
[(peak cross-section – diastolic cross-section) * 10 µm] 
DVL = 	 2
∙ 2 ∙ 0.35 ∙ − 2 ∙ 2 ∙ 0.35 ∙ ∙ 10
10  
where dP (µm) and ds (µm) are fully expanded and systolic diameters respectively, 0.35 
is the smaller transverse to the larger in the plane radius ratio and 103 is the µm3/pl 
conversion factor. 
SV and DVL are important determinants of lymph flow (LF, pL/min), which is the 
product of stroke/compliance volume and contraction frequency. They are also used to 
calculate ejection fraction (EF), which represents the volumetric fraction of lymph 
pumped by a lymphatic vessel at each pumping cycle and it is calculated as SV divided 
by diastolic volume or DVL divided by fully expanded vessel volume. 
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= 	 ∙  
= 	
2 ∙ 2 ∙ 0.35 ∙ ∙ 10
																													 = 	
2 ∙ 2 ∙ 0.35 ∙ ∙ 10
 
 
Data are presented as mean ± SE. Differences between mean values have been 
statistically evaluated with Student’s t-test  or ANOVA after data normality distribution 
check. 
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Part II 
3.4 In vivo experiments 
Animals (mean body weight: 286 ± 5 g,  n = 7) handling and surgical procedures were 
identical to the ones previously described. With the use of P-97 Flaming/Brown type 
Micropipette Puller (Sutter Instrument, Novato, USA), glass pipettes for microinjection 
were pulled from borosilicate glass capillaries (1B100-4, 1.0 mm outer diameter, 0.78 
mm inner diameter, WPI Europe, Berlin, Germany) to tip diameters of ∼25 μm and then 
they were beveled in order to reduce the damaging impact with the interstitial tissue. 
Pipettes were back-filled with mineral oil and mounted onto a mechanical microinjector 
(WPI Europe) set to deliver 9.2 nl/injection, at an injecting rate of 10 nl/sec. Under the 
stereomicroscope, pipettes were front filled with 1 μl of 1 M KCl solution (P9333 – 
Sigma Aldrich). With the use of a mechanical coarse/fine micromanipulator 
(Narishige), the pipette was placed next to the interstitium to be injected. Then, the 
pipette tip was gently advanced through the pleural diaphragmatic surface until it was 
placed under the mesothelial layer. A single injection of 9.2 nl of KCl 1 M was then 
triggered, and the pipette tip was immediately withdrawn from the diaphragmatic 
surface. 
Before, during and after the injection maneuver intraluminal lymphatic pressure (Plymph) 
was measured by the use of the micropuncture technique. Plymph recordings were 
attained through glass micropipettes pulled by P-97 Flaming/Brown type Micropipette 
Puller (Sutter Instrument, Novato, USA) and then beveled to a tip diameter of ∼2.5 µm. 
They were back-filled with 1 M NaCl solution and secured to a pipette holder filled 
with the same solution. The holder was connected to the dome of the motor driven 
pressure nulling system (Dual Servonull Pressure-Measuring System, Vista Electronics, 
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Ramona, CA)., in turn connected to a mineral oil-filled pressure transducer (Gould 
Instruments System). The pipette holder was mounted in a three-dimensional hydraulic 
micromanipulator (Joystick Micromanipulator MO-188 or MO-109, Narishighe) 
equipped with a fourth micromanipulator movement to drive the tip of the micropipette 
into the tissue. The pressure signal was relayed to an amplifier and a signal conditioner 
(model 6600, Gould Electronics), digitized with an analog-to-digital board, and 
displayed on the monitor using LabView software (National Instruments). Electrical 
zeroing of the recording system was performed before and immediately after each 
measurement by dipping the micropipette tip in a saline pool positioned at the same 
height of the pipette insertion point. Criteria for acceptance of the micropipette pressure 
recordings were a) an unchanged electrical zero of the system on withdrawal from the 
tissue compared with the pre-insertion value, b) a stable pressure reading for at least 10 
sec, and c) repeated measurements from the same area were within ±1 cm H2O. 
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3.5 Data analysis 
The effect of diaphragmatic striated muscle fibers contraction due to KCl exposition on 
diaphragmatic lymphatics was evaluated as diameter and/or vessel lengths changes 
before and after tissue contraction in lymphatic vessels which were perpendicular or 
parallel with respect to the striated muscle fibers orientation. As more lymphatics were 
analyzed in the same video in vivo recorded, three frames from video data referring to 
each injection were selected. They represented a) the completely relaxed diaphragmatic 
striated muscle fibers preceding the KCl injection into the interstitium, b) the maximum 
contraction of striated fibers following the KCl injection and c) the striated fibers 
relaxation after at least ~ 30 seconds after b. Data were also normalized as percentage of 






∆ = ∙ 100 
Where Δd is the effect of diaphragmatic striated muscle fibers contraction on lymphatic 
vessel diameter expressed as percentage of resting diameter, dpre,i (resting diameter) and 
dpost,i are diameter lengths pre- and post-muscular tissue contraction, respectively, Δdrel 
is lymphatic diameter after muscle relaxation, expressed as percentage of resting 
diameter and drel is diameter in c. Δl is linear lymphatic vessel shortening after 
diaphragm contraction (l1), expressed as percentage of l0. 
In transverse linear lymphatic vessels stroke volume (SV, expressed in pL) was 
calculated using mean values of compressed and resting diameters of each analyzed 
vessel. Based on previous evidences which revealed that the cross-sectional area of 
Materials and Methods 
84 
diaphragmatic lymphatics tends to be elliptical rather than cylindrical and the smaller 
radius in the plane perpendicular to the pleural surface is ∼35% of the parallel one (77), 
it was estimated or a lymphatic segment of 10 µm length as [(diastolic cross-section – 









2 ∙ 0.35 ∙ ∙ 10
10  
where dpre,i and dpost,i are diameters pre- and post-muscular tissue contraction 
respectively, 0.35 is the smaller transverse to the larger in the plane radius ratio and 103 
is the µm3/pl conversion factor. 
Similarly, the diastolic volume load (DVL, expressed in pL) was calculated using mean 
values of expanded and resting diameter lengths at each analyzed vessel. Also DVL was 
estimated for a lymphatic segment of 10 µm length as [(diastolic cross-section – systolic 









2 ∙ 0.35 ∙ ∙ 10
10  
where dpre,i and dpost,i are diameters pre- and post-muscular tissue contraction 
respectively, 0.35 is the smaller transverse to the larger in the plane radius ratio and 103 
is the µm3/pl conversion factor. 
In longitudinal lymphatic vessels DVL (pL) was differently calculated, by using mean 
values of compressed and resting diameters and lengths of each analyzed vessel. 
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2 ∙ 0.35 ∙ ∙
10  
where dpre,i and dpost,i are diameter pre- and post-muscular tissue contraction 
respectively, l0 and l1 are lymphatic vessel lengths pre- and post-muscular tissue 
contraction respectively, 0.35 is the smaller transverse to the larger in the plane radius 
ratio and 103 is the µm3/pl conversion factor. 
SV and DVL were also used to estimate ejection fraction (EF), which represents the 
volumetric fraction of lymph pumped by a lymphatic vessel at each compression and/or 
expansion due to extrinsic pump and it is calculated as SV divided by resting volume or 
DVL divided by expanded vessel volume. 
= 	
,





2 ∙ 0.35 ∙ ∙ 10
 
Mean values of Plymph were obtained from pressure recordings acquired with Labwiev 
custom software and analyzed by Clampfit 10.2 Software. Intraluminal pressure 
gradients (ΔPlymph) due to diaphragmatic muscle contractions were calculated as 
difference between mean intraluminal lymphatic pressures measured pre- (Plymph,1) and 
at the maximal muscle contraction (Plymph,2): 
∆ = , − ,  
The time interval between pressure pipette positioning and end-recording related to each 
injection was ~ 4 minutes. During this recording time, in order to avoid possible 
artifacts in Plymph measure, rats were temporarily disconnected from the ventilator and 
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oxygenated with a continuous intra-tracheal flux of 50% O2 in nitrogen at a continuous 
positive airway pressure of 7 mmHg, 
Data are presented as mean ± SE, with n being the number of analyzed sites. Typically, 
only one site for any given experiment was obtained from one vessel. Statistical 
significance was evaluated by paired or unpaired Student’s t-test or ANOVA after data 










4. Results and Discussion 
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Part I 
4.1 In vivo experiments 
4.1.1 In vivo diaphragmatic lymphatic network visualization 
In vivo lymphatic vessels labeling by peritoneal dye injection is a common technique in 
order to better visualize lymphatics, which are usually transparent lymph filled. In fact, 
the diaphragmatic lymphatic network can be visualised under a stereomicroscope 
equipped with a white light epi-illuminator (Fig 4.1 A). In these conditions, lymphatics 
appear as darker-than-background vessels lined by white borders. This kind of 
visualization is very useful to better appreciate the lymphatic vessel orientation with 
respect to the diaphragmatic striated muscle fibers. On the other hand, the disadvantages 
of this method mainly consist in the few vessels which can be visualized, most laying 
on top of the pleural diaphragmatic surface, and the impossibility to use an automatic 
system to measure the lymphatic vessel diameter length. This is why the diaphragmatic 
lymphatic network was in vivo stained using a FITC-dextran conjugated dye (Fig 4.1 
B), which allows a better vessel–to–background contrast and makes much more 
lymphatics detectable, even if they are not on the top of the pleural surface but 
immersed in the muscular tissue. The in vivo staining technique is based on the unique 
permeability of initial lymphatics to allow solutes larger than 70 kDa, such as the 
fluorescent dextrans, to cross their walls. By injecting FITC-conjugated 250 kDa 
dextrans in the peritoneal cavity, the only vessels which can be filled by these dextrans 
are lymphatics which drain the peritoneal cavity and the ones lying on the peritoneal 
surface of the diaphragm. Furthermore, the presence of intraluminal lymphatic valves is 
easier to identify in fluorescent-filled vessels, due to the inhomogeneous distribution of 
the tracer on the opposite sides of the valve. 
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On the other hand, under fluorescence epi-illumination the orientation of diaphragmatic 
muscle fibers is not always clearly detectable, as well as the presence of adipose tissue, 
which is primarily located in the extreme periphery of the muscular region. 
 
Figure 4.1 Pleural diaphragmatic lymphatic vessels. A and B: Diaphragmatic lymphatics can be 
visualized both in white epi-illumination (A) and fluorescence (B). Lymphatics which are distinguishable 
both in white light and fluorescence are superficial and mainly located in the muscular region of the 
diaphragm (pink dotted line), from the extreme periphery next to the ribs. C Merged image (green 
represents the FITC-fluorescent dye filled vessels). Scale bars 500 µm. 
 
Most studies in which diaphragmatic lymphatics were in vivo stained, for example by 
not specific ink-staining (80), were then analyzed ex vivo. In experiments like the ones 
presented here, such a method would have caused too much background staining when 
the diaphragm would be epi-illuminated with white light. On the contrary, there are no 
reports about in vivo diaphragmatic lymphatics labeling with an intraperitoneal injection 
of a lymphatic-specific marker such as podoplanin or Lyve-1, which is a common 
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technique to stain lymphatics locally (219). This is primarily due to the possible 
negative effects of a systemic exposition to the antibody, which would trigger an 
immune reaction. Moreover, the high volume of conjugated-primary antibody which 
should be injected in order to correctly stain diaphragmatic lymphatics would make it a 
too much expensive technique. Both intrapleural and intraperitoneal fluorescent dye 
injections can be performed in order to in vivo stain diaphragmatic lymphatics. 
Lymphatic vessels (not specific) fluorescent staining is commonly performed by 
injecting fluorescent-conjugated high MW dextrans which, in this case, can be drained 
from the serous cavities only by lymphatics, due to their large size. Based on previous 
evidences, the intrapleural dye injection results in a better dye invasion into the 
diaphragmatic lymphatic network (82). In fact, 30 minutes after the pleural injection, 
∼90% of the fluorescent dye can be found deep in the diaphragm, as after crossing the 
entire diaphragm it reached the peritoneal side. On the contrary, 30 minutes after the 
peritoneal injection only a small fraction of the fluorescent dye has reached the pleural 
surface. Based on these evidences, an intrapleural dye injection would have been 
preferable to better stain the diaphragmatic lymphatic network. On the other hand the 
high background staining due to the entire mesothelial pleural surface exposition to the 
fluorescent dye would impair the automatic diameter measurement. Moreover, a smaller 
volume of FITC-conjugated dye can be injected in the pleural space, because an 
increase in pleural fluid volume, mirroring pleural effusion, compromises the 
respiratory function. This is why an intraperitoneal injection had been performed to in 
vivo stain diaphragmatic lymphatics, with a following longer period of in vivo 
incubation. 
Mesenteric lymphatics are the most studied lymphatic vessels, mainly due to their great 
accessibility and the possibility to perform electrical, mechanical and pharmacological 
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in vivo and ex vivo studies on the full length vessels. Mesenteric lymphatics were found 
to be leaky to FITC-albumin (~ 4 nm in hydrodynamic radius, (220)), acting as 
exchange vessels which are able to extravasate solute and filter fluid (221). Unlike what 
was observed in those vessels, in our experiments diaphragmatic lymphatics were found 
not to be permeable to extravasation of FITC-fluorescent dextrans (~ 11 nm in 
hydrodynamic radius, (222; 223)) and microspheres mix injected into the peritoneal 
cavity. In fact, after 60 min of in vivo incubation and at least 150 min of video recording 
during the experiment, no fluorescent dye extravasated from the vessels lumen. 
 
4.1.2 Determination of lymphatic pumping activity 
In vivo fluorescence staining of diaphragmatic lymphatic vessels (85; 83) allowed us to 
identify much more diaphragmatic lymphatics than we could see by white light epi-
illumination. Diaphragmatic lymphatics fluorescence filling also allowed us to visualize 
both superficial vessels and deeper ones. Many of those fluorescent vessels were also 
found to be involved in active lymph propulsion, thus leading us to hypothesize that 
they could be strictly connected to parietal ones. 
The FITC-dextran in vivo stained vessels were sometimes located more deeply than 
those previously extensively investigated (77; 224; 76), both in the tendineous region 
and among the muscle fibers. Those which lay in the extreme muscular periphery, next 
to the ribs, are mainly organized in complex loop structures, which are wider than 
others in the muscle (on the right side of Fig 4.2 A) and connected by linear tracts. On 
the contrary no loops were found in the tendineous (on the left side of Fig 4.2 A) region, 
but only linear vessels, most of them organized longitudinally with respect to the 
diaphragmatic muscle fibers. The most peripheral vessels showed rhythmic diameter 
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changes during the in vivo video recordings. In lymphatics immersed in soft tissues, 
such as mesenteric lymphatics, most of these changes are due to active contractions 
which depend upon the smooth muscle layer in their vessel wall, both as pacemaker 
sites and showing a coordinated pumping activity along the network. 
 
Figure 4.2 Diaphragmatic lymphatics pumping activity. Lymphatics located in the extreme periphery of 
the diaphragm showed pumping sites, affecting vessel diameter. A Overview of the pleural lymphatic 
network of the right part of the diaphragm, in which complex loops are clearly distinguishable next to the 
ribs (pink dashed line, scale bar 500 µm). B and C Image sequence showing lymphatic vessels diameter 
changes in distinct sites (green arrowheads), which can be recognized in some tracts of the same network, 
whereas adjacent sites exhibited no diameter changes during the recording time (yellow arrowheads). 
 
Intrinsic pumping was extensively studied in mesenteric lymphatic vessels (156) and in 
the thoracic duct (225). However the thoracic duct and especially the diaphragm, are 
exposed to a physical environment that is very different from the one to which 
mesenteric lymphatics are exposed. Regarding diaphragmatic lymphatics, we found 
spontaneous changes in lymphatic vessels diameter only in those vessels which laid in 
the muscular peripheral region, next to the ribs, mainly in lymphatic loops. Indeed, 
diaphragmatic lymphatics running in the lateral to medial part of the muscular and 
tendineous diaphragm rely for their function only on the extrinsic mechanism (84; 83). 
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By modeling mechanical stresses affecting the diaphragmatic structure during cyclic 
respiratory movements, it was demonstrated that they are mostly located in the central 
stiffer tendineous region. On the contrary, minimal stresses appeared to be present in the 
peripheral muscle region (Negrini unpublished data). Thus, it is possible that smooth 
muscle elements in peripheral diaphragmatic lymphatics wall are required to supply the 
driving forces to sustain lymph formation and/or propulsion. Indeed, it is worth noting 
that inhibition of intrinsic contractile activity in the diaphragm reduces pleural 
lymphatic flow by ~ 40 % (81).  
At present, there is no report of lymphatic vessels pumping activity in the muscular 
diaphragm, in which lymph drainage and propulsion have always been thought to be 
primarily affected by extrinsic forces generated by cardiac and respiratory movements. 
On the other hand, in a very recent study performed in our laboratory (226), it was 
found that in some loops the flow direction not always follows pressure gradients but 
instead is able to revert multiple times with an average frequency of ~ 4 times per 
minute. In these vessels lymph progression is oscillatory, both simultaneously or in 
sequence in the same and/or different tracts of the same loop, not dependent on cardiac 
or ventilatory frequency.  
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4.2 In vitro experiments 
4.2.1 Localization of lymphatic smooth muscle 
Immunostaining for smooth muscle alpha actin (α-SMC), which is one of the most used 
markers in order to stain lymphatic smooth muscle (121), led us to confirm that 
diaphragmatic lymphatics possess smooth muscle elements in their vessels wall (227). 
In fact, confocal analysis of the whole mount immunostainings for s α-SMC (red signal 
in Fig 4.3 B) of previously in vivo recorded diaphragmatic lymphatic networks strongly 
emphasized the presence of smooth muscle fibers in the wall of several diaphragmatic 
lymphatic vessels. In fact, similarly to skeletal muscle (228) and myocardial (229) 
lymphatics, smooth muscle cells are scanty in costal (84) and diaphragmatic (48) 
lymphatic vessels. Therefore, at least in initial lymphatics, lymphatic function seems to 
primarily depend upon extrinsic pumps (83; 82), maybe supplemented by lymphatic 
smooth muscle intrinsic contractility. Data showed α-SMC immunoreactivity in almost 
all vessels previously in vivo FITC-labelled in the lymphatic network. 
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Figure 4.3 Smooth muscle α-actin lymphatic immunoreactivity. A: Peripheral lymphatics (green 
arrowheads) in vivo showing intrinsic pumping activity and not pumping vessels (yellow arrowheads). B: 
The whole mount staining for α-SMC, corresponding to the white dotted rectangle in A, highlights the 
presence of smooth muscle elements in the vessel wall of lymphatics of the entire network, whose 
disposition varies between contracting and not contracting sites (see text for details, green FITC-dextran 
dye, red α-SMC).(scale bars 500 µm). 
 
On the other hand, it is worth noting that the distribution of the smooth muscle fibers 
surrounding lymphatic vessels are not homogenous. In fact, results showed that the 
smooth muscle mesh arrangement was extremely variable: in contracting sites (Fig 4.4 
A and B) smooth muscle elements were organized in a dense mesh, completely 
encasing the lymphatic vessel (Fig 4.4 E), also visible in the inset showing the cross-
sectional area (Fig 4.4 E inset) taken at the white line position. Conversely, in not 
pumping sites (Fig 4.4 C and D) smooth muscle elements were also present, but they 
were more sparsely organized, showing a lot of large gaps around the vessel wall, as 
illustrated by the cross-sectional images (Fig 4.4 F insets). They also generally ran 
longitudinally to the vessel major axis, a way not adequate to compress the vessel and 
correctly propel the lymph flux. 
A B
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Figure 4.4 Smooth muscle elements in lymphatic vessels wall. A and B Still images showing an actively 
pumping lymphatic tract in vivo video recorded at different times. C and D Still images showing not 
pumping vessel in vivo video recorded at different times. (scale bars 250 µm). E α-SMC 
immunoreactivity of the same contracting site in A and B. F α-SMC immunoreactivity of the same loop 
in C and D (scale bars 100 µm). Insets show the cross-sections at the white lines in both panels E and F, 
(scale bars 25 µm). Green arrowhead pumping site, yellow arrowhead not contracting site. 
 
By analyzing the complex organization of smooth muscle cells surrounding 
diaphragmatic lymphatics with respect to video in vivo recorded showing spontaneous 
pumping activity it was evident that the presence of smooth muscle elements was not 
sufficient per se to explain the lymphatics behavior, since smooth muscle elements were 
found both in spontaneous pumping vessels and not pumping ones. Looking at Fig 4.4 
(E-F), it is clearly evident that the smooth muscle mesh organization in the lymphatic 
vessel wall is a key point in order to understand lymphatics function. In fact, in 
E F
A DCB
Results and Discussion 
97 
spontaneously pumping sites, a well organized smooth muscle layer can be found, 
whereas in other sites smooth muscle elements are mainly arranged transversally or 
oblique than longitudinally with respect to the lymphatic orientation, suggesting that 
lymphatic smooth muscle cells are not arranged in clear longitudinal and circular layers 
as in the gastrointestinal tract (230) but may be made up of strongly interconnected 
bundles of cells running in many different directions setting up a complex mesh. On the 
other hand the longitudinal orientation of smooth muscle fibers in most of not pumping 
lymphatic vessels is not unusual, as smooth muscle cells longitudinally oriented can be 
found in rabbit arteries (231). In this study we found that longitudinally oriented smooth 
muscle fibers surrounding lymphatics were always scanty and dispersed, not completely 
encasing the lymphatic vessel but, on the contrary, forming many gaps in the muscle 
layer. 
 
4.2.2 Detection of intraluminal lymphatic valves 
Lymphatic intraluminal valves were observed in both linear vessels and loops, where 
they are probably involved in the control of both flow direction and fluid recirculation. 
Intraluminal valves detection relies on the different FITC-conjugated dye accumulation 
on the opposite sides of the valve, as shown in Fig 4.5 A. The FITC-dextran flow 
direction follows the lymph flow, as reported in the diagram in Fig 4.5 B and backflow 
is prevented by valve closure, avoiding lymph leakage from the loop structures. 
Moreover, the FITC-dextran accumulates as reported in Fig 4.5 B (green), allowing to 
obtain the three-dimensional views shown in Fig 4.5 C and D. They were obtained as 
“negatives”: in fact they correspond to the fluorescent dye accumulated in the vessel 
and not to the intraluminal valve itself. Then, a color-code was applied to better 
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appreciate the three-dimensional overview: the funnel, in particular (Fig 4.5 C), is 
clearly recognizable in the lateral view. 
 
Figure 4.5 Lymphatic intraluminal valve. A The lymphatic valve is evident due to the different FITC-
dextran accumulation profiles at the opposite sides of the valve itself (scalebar 100 µm). B Diagram 
showing lymph flow direction and FITC fluorescent dye accumulation next to the funnel. C and D 3D 
projection of the intraluminal valve showing lateral (C) and frontal (D) views (scale bars 25 µm). In C is 
particularly evident the valve funnel. 
 
Intraluminal lymphatic valves gating depends on trans-valve pressure gradients, that 
allow lymph progression along the lymphatic network, which in turn depend on 
extrinsic and/or intrinsic forces acting on lymphatics. Particularly, in lymphatic vessels 
showing intrinsic contractility, during lymphatic systole the lymphatic smooth muscle 
cells contraction increases the intraluminal pressure. Given that the intraluminal 
Results and Discussion 
99 
pressure increases and that all adjacent lymphangions do not contract at the exact same 
time but sequentially, some lymph flows in the retrograde direction, closing the input 
valve of the lymphangion during the beginning of systole (105; 140). 
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4.3 Functional behavior of diaphragmatic lymphatics 
4.3.1 Lymphatics functional features 
Temporal profiles of diaphragmatic lymphatics diameter changes, which modulate the 
resistance to lymph flow, led to highlight the existence of vessels which propel lymph 
either actively or passively. Fig. 4.6 shows examples of the changes over time of the 
diameter of diaphragmatic lymphatic vessels simultaneously measured at four different 
sites of the same loop. The systematic examination was performed on 15 loops in vivo 
video recorded from 11 rats at 201 sites and allowed to define four different classes of 
lymphatics. In traces of Fig. 4.6 the downward deflection from the steady value 
corresponds to an active stroke, whereas upward deflections from the baseline value 
correspond to passive vessel enlargements. The analysis of Fig. 4.6 allows to distinguish 
vessels segments presenting active contractions (Fig 4.6 A and B) and others 
characterized by passive enlargemnts only (Fig 4.6 C). In addition, the contracting 
segment of Fig. 4.6A do not show any sign of fluid accumulation during the diastolic 
phase, as from the relative constancy of the baseline diameter, whereas in case of 
segment depicted in Fig. 4.6 B, there is a clear increase in vessel diameter before the 
beginning of the active stroke. Therefore we defined the segments behaving like that in 
panel A as pure actives and those similar to that in panel B as hybrids. Finally, the 
segment of panel D showed no diameter change over time and was therefore defined 
invariant vessels (Fig 4.6 D). 
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Figure 4.6 Different lymphatics behavior recognized based on the simultaneously recorded diameter 
changes vs time profiles. A Pumping site in which active spontaneous contractions were found. B Hybrid 
site showing a passive distension and a subsequent active contraction. C Passive compliant site. D 
Invariant not contracting site. 
 
Most of actively pumping lymphatic vessels, as the mesenteric ones, show features like 
pure active diaphragmatic lymphatics (156), in which the stroke causes the diameter 
length shortening and then after the vessel relaxation it returns back to the initial 
diastolic length. Moreover, most of the analyzed diaphragmatic sites belonged to this 
class. This kind of contraction results in a rapid reduction of the lymphatic diameter 
length, a decrease in lymphatic compliance, an increase in the local lymph pressure, the 
closure of the upstream valve, the opening of the downstream valve, and the ejection of 
lymph into the next downstream lymphangion and can be explained by cardiac analogy 
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was encountered in lymphatic vessels investigated in this study, only located on the 
extreme periphery of the pleural surface of the diaphragm. Data related to the estimated 
compliance of deeper diaphragmatic vessels (224), which is similar to the one of 
mesenteric lymphatics (87), also suggests that in lymphatics not encased in a stiffer 
tissue (as the tendineous or muscular diaphragmatic ones) the smooth muscle layer also 
supplies the correct mechanical support, thus confirming the strong environmental 
effects on lymphatic functions.  
On the other hand several diaphragmatic lymphatic sites showed a not pumping 
behavior, as their diameter never changed during the recording periods and they were 
classified as invariant sites. Since in vivo recordings were performed after blocking the 
respiratory movements, one cannot exclude that those invariant sites may exhibit a 
different behavior during spontaneous breathing. Unfortunately such a condition cannot 
be evaluated by the experimental setup used for this study performed in open chest. 
Indeed, since intrinsic pumping activity can be modulated by pharmacological or 
mechanical stresses too (129; 50; 232), one cannot exclude a similar effect on not-
pumping vessel. In fact, very recent data from ongoing experiments seem to indicate 
that mechanical stimulation of diaphragmatic lymphatics, due to diaphragmatic skeletal 
muscle fibers contraction, induced pumping activity in invariant sites which were not 
directly mechanically stimulated, leading to hypothesize that pumping activity in those 
diaphragmatic lymphatics could at least in part be mediated by lymph flow. 
 
Vessels belonging to different classes were interconnected in the very same loop. For 
example, in the network reported in Fig 4.7, the upper part of the loop was involved in 
the active lymph propulsion (violet line), whereas the lower part showed passive 
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compliant behavior, maybe acting as a passive lymph reservoir (green line). An hybrid 
tract (light blue line) was also present among them. Moreover, lymph entered the loop 
from the actively pumping upper input branch, running in parallel in both arms of the 
loop towards the invariant (pink line) lower output branches. 
 
Figure 4.7 Different mechanical behavior of adjacent lymphatic tracts. Different regions belonging to the 
same network showed different mechanical behavior: an active pumping tract (violet line), a passive 
reservoir region (green line), a tract showing hybrid features (light blue line) and two invariant branches 
(pink line) were identified (scale bar 500 µm). 
 
This kind of data analysis led us to understand that there is an extremely well structured 
functional organization in lymphatic loops and, in particular, that hybrid and/or pure 
passive regions are always in conjunction with pure active ones, as they also contract or 
enlarge with the same active sites frequency, forming functionally distinct regions 
which cooperate in order to correctly propel lymph fluid. 
Most of active pumping sites, arranged in actively pumping regions are also surrounded 
by adipose tissue, as it is clearly evident in Fig 4.7. In fact, the violet dotted line 
highlights the active propelling tract which is the region of the lymphatic loop in which 
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adipose tissue can be extensively identified. Although the presence of lymphatic 
capillaries have not yet been completely clarified within adipose tissues, adipose tissue 
generally surrounds most of collecting lymphatic vessels and lymph nodes (233). 
Particularly, a study by Pond and colleagues (234) had defined this perilymphatic 
adipose tissue as being metabolically essential for proper immune responses and as a 
source of energy for immune activation and proliferation. Recent evidences indicating 
an increase in mesenteric lymphatic vessel contractility in the presence of oxidized low 
density lipoproteins (ox-LDL) suggest a direct effect of lipids on lymphatic contractility 
(235). However, the precise mechanisms by which this occurs and the impact of lipid 
metabolism on lymphatic functions are poorly understood. Moreover, as mesenteric 
lymphatics mainly drain nearly all lipids absorbed from nutrients, whether there is a 
causal relationship between lipid content in the lymph and fat deposition is not known. 
 
Pure active lymphatics displayed periodic contractions alone and represent the major 
share of diaphragmatic lymphatics, with 52 % of analyzed sites falling therein. Their 
mean diastolic diameter was 161.98 ± 5.62 µm (n = 102) and no statistical differences 
were found between sexes. Vessel contraction made the systolic diameter significantly 
shorter than the diastolic, with a mean value of 74.55 ± 1.23 % (p<0.01 with respect to 
their diastolic diameter, paired t-test, n = 102; 120.16 ± 4.77 µm, p<0.01 with respect to 
their diastolic diameter, paired t-test, n = 102, Fig 4.8, violet bars). The mean 
contraction frequency of active vessels was 6.96 ± 0.37 bpm (n = 102). 
Hybrid vessels showed a very complex behavior since the firstly expanded reaching a 
diameter peak value and subsequently contracted to a smaller systolic diameter . They 
represent the minor share of diaphragmatic lymphatics, with 4 % of analyzed sites 
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falling in this class. The mean value of their resting diameter was 147.16 ± 13.25 µm (n 
= 8), rising up to 123.86 ± 7.62 % of resting value (p<0.01, paired t-test, n = 8; 179.12 ± 
13.35 µm, p<0.01 with respect to resting diameter, paired t-test, n = 8) and then falling 
to 66.02 ± 1.61 % (p<0.01, paired t-test, n = 8; 96.89 ± 8.58 µm, p<0.01 with respect to 
resting diameter, paired t-test, n = 8) of the diastolic diameter (Fig 4.8, light blue bars). 
The mean contraction frequency of hybrid vessels was 2.46 ± 0.13 bpm (n = 8). 
Relaxation time constant, τ was found to be significantly higher in active pumping 
vessels (2.66 ± 0.13 sec) than in hybrid lymphatics (1.73 ± 0.28 sec, unpaired t-test, 
p<0.05). 
Passive compliant lymphatics represent 5 % of analyzed sites. Their mean diastolic 
diameter was 185.95 ± 32.16 µm (n = 9) and increased to 133.63 ± 7.32 % ( p<0.01 
with respect to diastolic diameter, paired t-test, n = 9) with respect to resting diameter 
(237.06 ± 36.96 µm, p<0.01 with respect to diastolic diameter, paired t-test, n = 9, Fig 
4.8, green bars) due to lymph flow, with a relaxation frequency of 2.86 ± 0.51 bpm (n = 
9). 
Contraction frequency and/or vessels enlargement frequency were not affected both by 
respiratory cycle (71 ± 3 breaths/min) and heart rate (118 ± 9 bpm, at 122 ± 7 cm H2O 
blood pressure measured at the carotid artery with the chest wall open). 
Invariant lymphatics showed a diastolic diameter never changing during the recording 
periods, with 40% of analyzed sites falling therein. Their mean diameter was 154.37 ± 
7.40 µm (n = 78), not statistically different from the diastolic diameter of all the other 
classes (p = 0.448, one way ANOVA, 196 d.f, Fig 4.8, pink bars). 
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Figure 4.8 Diaphragmatic lymphatics diameter changes. A Mean resting diameter length for the four 
classes of lymphatics (solid color bars) compared with systolic (hollow dotted bars) and fully expanded 
(hollow dashed bars) diameter (** p<0.01 vs resting diameter). B Systolic and fully expanded diameter vs 
diastolic difference, expressed as percentage, with respect to 100% (diastolic diameter, ** p<0.01). 
 
Despite we found no difference in lymphatic mean diastolic diameter (Fig 4.8) between 
the four analyzed classes of diaphragmatic lymphatics, more than 90% of them 
belonged to pure active or invariant classes. Interestingly, active and invariant sites 
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4.3.2 Relationship between amplitude of contractions and resting diameter in active 
vessels 
Looking at active pumping vessels, Δ contraction (diastolic – systolic diameter, 
expressed as percentage of diastolic diameter) in each site was found to be different 
from each other. In fact, the analysis of all 102 actively pumping sites highlighted an 
extreme variability among their contraction amplitudes, ranging from 4.8 % to 66.5 % 
of their diastolic diameter. It was then investigated the possible existence of a Δ 
contraction dependence on the resting diameter and data were grouped based on the 
diastolic diameter in classes of 50 µm increments. As reported in the graph showed in 
Fig 4.9, concerning Δ contraction, no significant differences were found among all 
groups (p = 0.257, one way ANOVA, 100 d.f.), thus allowing to conclude that Δ 
contraction of active pumping sites is independent from diastolic vessel diameter. 
 
Figure 4.9 Δ contraction of active pumping sites which varied in size.  
 
It is interesting to note that hybrid sites contract and/or enlarge with a contraction 
amplitude not different from pure active or passive sites. The same contraction 

















Results and Discussion 
108 
pumping adult rat mesenteric lymphatics, which was found to be slightly reduced by 
aging (~ 20% with respect to resting diameter, (236)). 
Generally, the frequency and amplitude of lymphatic contractions vary significantly 
(237). Benoit and colleagues (101) found that the mesenteric lymphatics showing phasic 
contractions had mean resting diameter of ~ 70 µm and a contraction amplitude of ~ 
43% of diastolic resting diameter. In another paper, the same authors found that 
lymphatics with mean resting diameters of ~ 110 µm had a contraction amplitude of ~ 
35% of diastolic resting diameter (186). Galanzha and colleagues (238) found that 
lymphatics which had mean resting diameters of ~ 150 µm had an amplitude of ~30%. 
Hence, these data indicate that generally larger lymphatics have smaller amplitude of 
phasic contractions. Conversely, in diaphragmatic lymphatics we found that the 
contraction amplitude of actively pumping vessels is independent on the lymphatics 
diameter. 
Notwithstanding no contraction amplitude variability was found among actively 
pumping sites of different size, they were extremely variable in both their diastolic and 
systolic radii (Table 4.1). Fluid flux (J) in an ideal vessel is given by Poiseuille’s Law 
=
∙ ∙
8 ∙ ∙  
where ΔP represents the pressure hydraulic gradient which drives fluid flux, η is fluid 
viscosity and l is the vessel tract length. Thus, an extreme variability in diameter would 
greatly affect lymph flux, therefore lymphatic vessels diameter appears quite 
homogenous within the same loop structure, even if their diameters also vary between 
adjacent loops. 
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Table 4.1 Summary of Δ contraction mean values of active pumping sites which were grouped based on 
their diastolic diameter (d) in steps of 50 µm. Mean diastolic radius (r) and systolic r are also reported. 
 
4.3.3 Relationship between amplitude and frequency of contractions in active vessels 
The variability of contraction amplitudes among actively pumping sites was also 
investigated in order to identify its possible dependence on contraction frequency. In 
fact, a great variability in contraction frequencies was also found in this class of vessels, 
ranging from 2.2 bpm to 17.4 bpm, even if contraction frequency was found to be 
independent from vessel size (data not shown). 
Δ diameters (systolic - diastolic diameter change) were plotted (Fig 4.10) as a function 
of contraction frequency.  
interval (µm) n mean d (µm) Δ contraction (%) p value mean r (µm) systolic r (µm)
50 - 100 14 80.65 ± 3.36 22.31 ± 3.31 no 40.33 ± 1.68 31.45 ± 1.31
100 – 150 34 129.95 ± 2.41 23.54 ± 1.64 no 64.97 ± 1.20 50.03± 0.93
150 - 200 31 173.02 ± 2.37 27.51 ± 1.97 no 86.51 ± 1.19 63.15 ± 0.87
200 - 250 15 222.02 ± 3.26 29.48 ± 4.02 no 111.01 ± 1.63 78.82 ± 1.16
> 250 8 285.10 ± 6.56 23.45 ± 7.30 no 142.55 ± 3.28 109.77 ± 2.53
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Figure 4.10 Dependence of vessel Δ systolic - diastolic diameter as a function of corresponding 
contraction frequency in active lymphatic vessels: data were classified based on contraction frequency 
and plotted as mean values of each resulting group (see the text for further details). 
 




where (y0 = 3.94, a = 71.92, b = 2.27). Although quite dispersed, data tended to 
significantly (n = 14, r2= 0.84, p < 0.01) decrease with increasing frequency, indicating 
that the relationship between diameter change and contraction frequency tended to keep 
the flux at a steady value inside the same structure (see paragraph 4.3.5).  
Such a kind of inverse relationship was also described by Amerini and colleagues (239) 
by investigating the modulatory effects of substance P administration to rat mesenteric 
lymphatics. In that study, SP increased basal tone and chronotropy but reduced both 
systolic and resting diameter lengths, leading to a reduction in spontaneous contraction 
amplitude. Also Gasheva and colleagues (225) found a positive chronotropic effect 
frequency (bpm)
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compensating the reduction of contraction amplitude by testing the modulatory effect of 
l-NAME on spontaneously pumping lymphatics, since fractional pump flow (EF ∙ CF)  
did not significantly changed during the NO synthase blockade. 
 
It is worth noting that Δ diameter and frequency heterogeneity were encountered also 
within the same lymphatic network. For example, plotting data related to a single 
network in a Δ diameter vs frequency graph resulted in the identification of two 
separated classes, both in Δ diameter and cycle frequency (Fig 4.11). The low frequency 
class (n = 8) had a mean contraction frequency of 5.7 ± 0.3 bpm and a mean value of Δ 
diameter of 28.0 ± 1.5 %, whereas the high frequency class (n = 7) had a mean 
contraction frequency of 13.5 ± 0.5 bpm (unpaired t-test, p<0.01) and a mean value of Δ 
diameter of 7.9 ± 1.1 % (unpaired t-test, p<0.01), thus confirming existence of two 
functionally distinct loops which cooperated in the same lymphatic network. 
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Figure 4.11 Different regions in the same lymphatic network show significantly different Δ diameter vs 
frequency values. In regions of the loop where the contraction frequency is low (Lf), Δ diameter is large, 
(grey dotted rectangle) whereas where contraction frequency is high (Hf) Δ diameter is about three fold 
lower (white dotted rectangle). Scale bar 500 µm. 
 
In general, the functional diversity of smooth muscle elements is characterized by the 
different contractile activity: phasic smooth muscle cells which can be found in 
gastrointestinal tract exhibit rhythmic rapid shortening and relaxing cycles, whereas 
tonic smooth muscle cells which are found in blood vessels wall have slower shortening 
velocities and prolonged contraction (240). We found that mean value of contraction 
frequency of pure active peripheral pumping lymphatics of adult rats was ~ 6 bpm, a 
value in close agreement with that of Benoit (101) and Akl (236) ( ~ 6 - 9 bpm). As 
lymphatic vessels actively contract to regulate lymph fluid transport, the lymphatic 
contractions which drive lymph propulsion (phasic brief contractions) and the ones that 
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lymphatic network, thus probably explaining the existence of, respectively, high- and 
low-frequency active pumping sites. 
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4.3.4 Functional parameters in lymphatics 
In order to standardize data obtained from vessels of different lengths and based on the 
evidence previously reported (77) that in diaphragmatic lymphatics the ratio between 
the diameter perpendicular to the pleural surface and the superficial one is 0.35, it had 
been possible to calculate SV, DVL, EF and LF in a vessel tract arbitrarily set 10 µm 
long. 
 
Table 4.2 Lymphatics mechanical parameters. Stroke volume (SV, for contracting vessels) and diastolic 
volume load (DVL for vessels which underwent to an enlargement) were normalized and expressed as 
ejection fractions, i.e. as % of the end-diastolic volume . SV and CV were also used to estimate lymph 
flux. 
 
SVs of active pumping sites were normalized with respect to diastolic volumes whereas 
SVs and DVLs of hybrid and passive sites were normalized with respect to fully 
expanded vessel volumes and expressed as EFs. The EF represents the average 
volumetric fraction of lymph propelled with each vessel contraction or accommodated 
with each passive vessel enlargement. As reported in Table 4.2, the EF was similar (p = 
0.667, unpaired t-test) in active pumping sites and adjacent passive ones, whereas 
hybrid sites had an higher EF with respect to both active (p<0.01, unpaired t-test) and 
passive (p<0.01, unpaired t-test) sites due to the vessel enlargement which preceded the 












active 34.9  ± 3.0 n.a. 43 ± 2 6.96 ± 0.37 199.3 ± 13.9
invariant n.a. n.a. n.a. n.a. n.a.
hybrid 64.4 ± 9.7 28.7 ± 6.7 70 ± 3 2.46 ± 0.13 152.6 ± 20.5
passive n.a. 66.7 ± 24.4 40 ± 6 2.86 ± 0.51 106.7 ± 50.6
p value p < 0.01 no p < 0.01 - no
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Focusing on the EF of the major class of diaphragmatic lymphatics sites (i.e active 
pumping ones) which corresponds to 43 % of lymphatic diastolic volume, it is worth 
noting that it is significantly lower than mesenteric lymphatics one (~ 67 %, (101)), thus 
suggesting that diaphragmatic lymphatic function efficiency may be improved by the 
cooperation with extrinsic forces that can affect the very same vessels. 
Moreover, it is worth to remind that hybrid, passive or purely active segments, all 
belonged to the same loops . Most of these peripheral loops are composed of purely 
active and invariant segments: in these loops the purely active segments display the 
highest frequency of contraction (up to 17 bpm, mean value of all active pumping sites 
is about 7 bpm). In fewer loops, purely active segments are accompanied by passive and 
hybrid ones: in this cases the purely active contractile frequency is lower (about 3 bpm) 
and the hybrid segments contraction and relaxation of the passive segments follows the 
contraction frequency of the pure active ones to which they are in close proximity. 
 
4.3.5 Lymph flux 
The analysis of 8 loops in 7 lymphatic networks (n = 68 active pumping sites) pointed 
out that lymph flux was almost constant in each loop structure. In fact, as in 
diaphragmatic lymphatics the contraction amplitude of actively pumping vessels is 
independent on the lymphatics size but it is dependent on the vessels contraction 
frequency, the product of diameter change times frequency lead to an almost constant 
flow. 
Particularly, two analyzed loops showed the same contraction frequency in the whole 
structure, whereas in six loops contraction frequency but not lymph flux (Fig 4.12) 
varied in adjacent segments of the same loop. 
Results and Discussion 
116 
 
Figure 4.12 Diaphragmatic lymphatic loop in which eight active pumping sites showed different 
contraction frequencies but lymph flow was found to be relatively constant (scale bar 500 µm). 
 
The only exception found was a double loop structure in which lymph flux was 
significantly different (Fig 4.13). In fact in a loop (corresponding to the Low contracting 
frequency structure in Fig 4.11) lymph flux was 145.28 ± 16.78 pL/min (n = 8) whereas 
in the adjacent one (corresponding to the High contracting frequency structure in Fig 
4.11) lymph flux was significantly lower, 58.56 ± 7.29 pL/min (p < 0.01, unpaired t-
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Figure 4.13 Different segments of the same loop (dark grey or white symbols) maintain a roughly 
homogenous lymph flux within itp. However, adjacent loops in the same lymphatic network show a 
significantly different lymph flux. 
 
To understand the features of fluid movements, lymph propulsion along the network 
was calculated in different regions of the same loop. For example, as reported in Fig 
4.14 A, lymph flux was estimated in each pumping site (white circles) and in external 
branches connected to the loop (light blue circles). For each analyzed site lymph flux 
(pL/min) is indicated next to the site itself. In vivo video recordings allowed to detect 
fluid recirculation in the complex loop structure, which is represented in Fig 4.14 B by 
the arrow colors: fluid moved and reflowed from the light blue top left loop to the violet 
top right one and finally to the lower left blue loop. The graph reported in Fig 4.14 C 
shows the lymph flux (Jl) in the three adjacent and correlated structures (same colors as 
in B), highlighting the existence of a Jl variability of ~ 150 pL/min among different 
adjacent loops. Pooling together data from the entire network allows to identify 
different tracts acting as input (Fig 4.14 B, yellow arrowheads) or output (Fig 4.14 B, 
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superficial vessels and running perpendicularly to them, thus explaining the presence of 
Jl variability in some loop tracts, cannot be excluded. On the other hand, the 
fluorescence epi-illumination of diaphragmatic lymphatics used in this kind of 
experiments does not permit their eventual detection. 
 
Figure 4.14 Lymph flux in a lymphatic loop. A Lymph flux was estimated both in loop pumping sites 
(white circles) and external branches (light blue circles). Lymph flux data are reported next to the site and 
are expressed as pL/min. B Lymph flow direction in three adjacent loops (depicted with different colors) 
is indicated by white arrowheads. The picture also shows input (yellow arrowheads) and output (orange 
arrowhead) branches. (scale bars 250 µm). C the graph show lymph flow (Jl) in the same three adjacent 


































path along the loop
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Notwithstanding in the same loop lymphatic sites with different pumping properties 
coexist, they all collaborate to attain a steady flux in the closed loop structure. This 
could point to the fact that even when an apparent disorganization exists, there must be 
a sort of order which keeps lymph flux almost constant. 
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4.4 Temporal analysis 
4.4.1 Temporal correlation among sites belonging to the same lymphatic network 
Although lymphatics diameter, contraction amplitude and contraction frequency affect 
lymph flow, only two parameters characterize the coordination between different 
pumping sites and the resulting contraction waves: a) the time delay between the onset 
of contractions of adjacent sites (for synchronous contractions) and b) the relative 
contraction frequency between adjacent sites (for asynchronous contractions). 
As explained above, vessels belonging to the four different classes can be identified in 
the same lymphatic structure; therefore we performed a temporal analysis of the local 
activity of a lymphatic segment with respect to the immediately adjacent sites. To this 
aim a cross-correlation analysis of simultaneously recorded diameter changes over time 
was performed. For example, a zero lag was found between a passive compliant site and 
the adjacent active or hybrid one. Moreover, zero lag was also found between all 
passive compliant adjacent sites, thus confirming the existence of a region showing 
passive mechanical features (lower right region of the loop in Fig 4.15) which was 
functionally defined as a passive reservoir (see also Fig 4.7). In fact, passive vessels 
enlargement was strictly connected to the active pumping of other sites in close 
proximity to them.  
On the other hand, several actively pumping sites can coexist in the same loop structure, 
as reported in Fig 4.15 (b, c and d). In this loop structure, sites ‘b’ and ‘c’ displayed a 
strongly correlated intrinsic pumping activity, with the same contraction frequency of 
3.1 bpm and a lag of 0.5 sec (c vs b), underling the trigger role of site ‘b’. Also the 
passive compliant site ‘a’ had the same contraction frequency, with a 0.95 sec delay 
with respect to site ‘b’, being farther away from the trigger site. A higher frequency 
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contracting site was also found in the same loop, since site ‘d’ showed a contraction 
frequency of 5.4 bpm, which was also found to be uncorrelated to other regions in the 
same loop structure.  
 
Figure 4.15 Diameter profiles simultaneously recorded in different sites of the same lymphatic loop . a 
passive compliant vessel, b and c correlated actively pumping sites (b is the command site). d 
uncorrelated active pumping site (scalebar 500 µm). 
 
Results indicate that coordination among active pumping sites exists in diaphragmatic 
lymphatics, a well organized functional mechanism also previously described in 
mesenteric (106) lymphatic vessels, which allows the correct lymph flux along the 
network. In fact, all active pumping sites contributed to the ordered propulsion of the 
lymph in the network, as highlighted by the image sequence reported in Fig 4.16, in 
which a fluorescent aggregate (see image sequence below), as expected on the analysis 
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Figure 4.16 Image sequence of a fluorescent microspheres aggregate reflowing counterclockwise along 
the lymphatic loop during the recording period. 
 
Pooling together data from different loops in which adjacent sites had the same 
contraction frequency and no zero lag between them, it had been possible to calculate 
the apparent “spread” of the contraction wave along the network, by dividing their 
distance by the time lag of contractions. This computation gave a mean spreading 
velocity of the contraction wave of 1.31 ± 0.34 mm/sec (n = 5 loop structures). In spite 
of an high spread velocity of contraction waves in mesenteric lymphatics (4 – 8 
mm/sec), in diaphragmatic lymphatics active contractions propagate slowly, probably 
due to the complex organization of the lymphatic network. In fact, low propagation 
velocity may favor lymph recirculation along the whole network and particularly in the 
loops, whereas mesenteric lymphatics are mainly linear. 
Lastly, it had been reported that the coordination of lymphatic contractions can be 
modulated, for example, by temperature. In fact, by changing the temperature of the 
lymphatic tract, it is possible to cause contraction waves to propagate in both an 
“orthograde” direction (following flow direction) and a “retrograde” direction (opposite 
to flow direction, (135)). This finding represents a key point for future perspectives, as 
0 sec 25.50 sec 51.70 sec
106.65 sec 113.05 sec
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both modulatory drugs and mechanical stimuli should be tested in order to evaluate their 
effect on diaphragmatic lymphatics function. 
 
4.4.2 Identification of lymphatic pacemaker sites 
The determination of the general characteristics of the contractile waves propagation 
along the lymphatic network provides important information of the role of the 
pacemaker in the coordination of the pumping activity through lymphatics. Such 
information are necessary to clarify the potential role of the disorder affecting lymphatic 
electrical events in the pathogenesis of various diseases, which can lead to diminished 
lymph flow and formation of local edema. Based on temporal correlation analysis, 
multiple pacemaker sites can be identified in different diaphragmatic lymphatic network 
tracts. Following Akl and colleagues (236), the time delay between the contractile 
waveforms from two consecutive axial positions along the vessel can be measured and 
used to calculate the propagation velocity. If a vessel has a single pacemaker site near 
the middle, the contractile waves propagate away from the pacemaker site in opposite 
directions and the propagation velocity changes from negative (to the left of the 
pacemaker site), to positive (to the right of the pacemaker site, type I zero crossing). If 
instead a vessel has two pacemaker sites, then two contractile waves propagate in 
opposite directions toward each other resulting in a collision site, where the velocity 
changes from positive to negative (type II zero crossing). 
The graph in Fig 4.17 shows the average contraction wave velocity (mm/sec) of five 
consecutive contractions in adjacent sites along a lymphatic tract of about 1800 µm (left 
panel of Fig. 4.17). The contraction wave velocity changes sign two times from 
negative to the positive direction, which correspond to the zero-crossings visible in the 
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graph reported in Fig 4.17. The former was identified between sites 1 and 2 in Fig 4.17, 
leading to hypothesize the possible presence of a pacemaker site located between 364 
and 859 μm from the site arbitrarily set to zero. The second change of contraction wave 
velocity from negative to positive direction was identified between sites 3 and 4 of Fig 
4.17, thus we hypothesized the presence of another pacemaker site located between 
1320 µm and 1711 µm.  
 
Figure 4.17 Contraction wave propagation velocity in four adjacent lymphatic tracts (regions 1-4), 
corresponding to the ones reported on the left. The figure also shows the distance of four different sites 
from a reference site arbitrarily set to 0.00 µm (scalebar 500 µm).  
 
Temporal analysis between diameter profiles led us to assess that at least two 
pacemaker sites cooperate to sustain fluid flux in the observed loop. In fact, the image 
sequence reported in Fig 4.18, referring to the in vivo video recording of about sixty 
seconds of the active pumping activity in this lymphatic network tract, highlights the 
presence of two pacemaker sites (Fig 4.18 arrowheads, panels C and G) and the 
collision site in between them (Fig 4.18 arrow, panel M). It is worth noting that the two 
pacemaker sites acted in a coordinated manner but not simultaneously to correctly 
propel the lymph fluid. Particularly, the not FITC-stained dark lymph entered from the 
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contracted (Fig 4.18 panel C), whereas it was pushed in the reverse direction when the 
second pacemaker site contracted (Fig 4.18 panel G).  
 
Figure 4.18 Image sequence showing the coordinated pumping activity of two pacemaker sites 
(arrowheads) flanking the collision site (arrow, see text for further details), over a period of about sixty 
seconds. 
 
It is well known that actively pumping lymphatic vessels, independently on their 
location in the body or on their main functional involvement, transport lymph fluid by 
rhythmic constrictions of the lymphatic smooth muscle cells in their vessel walls. 
Particularly, studies on mesenteric lymphatics of the guinea pig demonstrated the 
existence of the pacemaker mechanism (137), underlying that the generation of L-type 
Ca2+ channel-mediated action potentials and associated constrictions are due to a 
summation of spontaneous transient depolarizations (STDs). L-type Ca2+-channels are 
voltage-gated and open in response to the suprathreshold depolarization of the smooth 
muscle membrane, which is generated by an electrical event, named pacemaker 
potential. Despite further analysis are required to determine electrical features of 
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diaphragmatic lymphatic smooth muscle cells (and their associated endothelial cells) in 
order to understand the pacemaker behavior of some of them, the present study 
indicates that lymphatic pacemaker sites exist in the peripheral portion of the 
diaphragmatic lymphatic network. 
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Part II 
4.5 Preliminary results  
This Part II of the research work, still ongoing, aims at investigating the contribution of 
diaphragmatic striated muscle fibers active contractions in lymphatic function. The 
effect of diaphragmatic muscle contraction during the active respiratory cycle on 
diaphragmatic lymphatics was mimicked by KCl 1 M injection into the interstitium next 
to the very same vessel. Pleural lymphatic loops previously investigated from a 
functional point of view mainly displayed intrinsic pumping activity during the in vivo 
experiments. On the contrary, KCl 1M effect was evaluated in parallel and 
perpendicular lymphatics (relative to the diaphragmatic skeletal muscle fibers 
orientation), which were found to be mostly invariant vessels and also less peripheral 
than lymphatic loops. By locally injecting 2.3 nl of KCl 1M solution (KCl from now 
onwards) no effect was found on those lymphatic vessels (data not shown) and then 
multiple injection into the interstitium were performed. Occasional muscle contractions 
were found by injecting 6.9 nl of KCl, whereas maximal local effects were found after 
9.2 nl of KCl injection. Thus this KCl volume had been used to perform the experiments 
described in Part II. 
 
4.5.1 Diaphragmatic muscle contraction effect on perpendicular lymphatics 
To distinguish between different components contributing to the extrinsic pump, the 
effect of diaphragmatic muscle contraction was evaluated by selective contraction 
induced by KCl exposition. KCl application is often used as a tool to activate muscle 
contraction by changing the K+ equilibrium potential and causing a membrane 
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depolarization which increases cell membrane potential at some value above the resting 
level (242). Membrane depolarization increases intracellular calcium concentration 
[Ca2+]i: which regulates muscle contraction of both striated and smooth muscles, albeit 
with significant intracellular differences, which are however not relevant to the present 
work (243; 244).  
In our analysis we considered long diaphragmatic vessels belonging to lymphatic loops 
and running either parallel or perpendicular to the skeletal diaphragmatic underlying 
fibers: vessels exhibiting a pumping-like activity were excluded from the analysis.  
Muscle contraction effect on perpendicular lymphatics was found to be dependent both 
on the distance from the KCl injection site and on the functional features of the 
lymphatic vessel itself. As shown in Fig. 4.19, striated muscle contraction next to the 
vessel (distance < ~ 300 µm) produced a marked constriction of the lymphatic vessel 
(violet arrow, Fig.6.1, 12.). On the contrary, striated muscle contraction far from the 
vessel (distance > ~ 900 µm) pulled one side of the vessel, thus causing an increase of 
the apparent vessel diameter (Fig 4.19, green arrow). Muscle contraction initiated by 
KCl administration at distances in between 300 and 900 µm gave mixed results, 
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Figure 4.19 Timeframe showing the effect of diaphragmatic muscle contraction on perpendicular 
lymphatics (striated muscle fibers orientation highlighted by white dotted line) next (contraction) or far 
(expansion) to the injection site: 1 sec corresponds to the injection frame, 12 sec to the maximal striated 
muscle fibers contraction and 66 sec to the diaphragm relaxation. KCl was injected into the interstitium as 
indicated by yellow arrowhead. Violet arrow indicates the effect of diaphragm contraction on the closer 
site whereas green arrow indicates the effect on the far site. Scalebar 250 µm. 
 
Two population of compressing perpendicular lymphatics were found, which showed a 
greater (Fig 4.19 violet arrow) or less (Fig 4.20 violet arrow) sensitivity to skeletal 
muscle contraction.  
 
Figure 4.20 Timeframe showing the effect of diaphragmatic muscle contraction on a perpendicular 
lymphatic (striated muscle fibers orientation highlighted by white dotted line) next (contraction) to the 
injection site: 1 sec corresponds to the injection frame, 5 sec to the maximal striated muscle fibers 
contraction and 48 sec to the diaphragm relaxation. KCl was injected into the interstitium as indicated by 




Results and Discussion 
130 
The extrinsic pump effect on perpendicular compressing lymphatics is reported in Fig 
4.21 and 4.22. As clearly evident, two population of perpendicular vessels were found. 
The most significant effect (Fig 4.21) was found in lymphatics with mean resting 
diameter of 165.12 ± 10.38 µm which decreased to 89.48 ± 7.68 µm (p < 0.01, paired t-
test vs resting diameter, n = 13) after skeletal muscle contraction After diaphragm 
relaxation lymphatic diameter reached 150.11 ± 9.28 µm, a value significantly higher (p 
< 0.01, paired t-test, n=13 ) than that observed at maximum skeletal muscle contraction. 
On average, lymphatic vessel diameter decreased to 53.6 ± 2.3 % of resting diameter 
(Δd, p < 0.01, paired t-test vs the respective resting diameter set to 100%, n = 13) and 
returned to 91.3 ± 2.2 % of resting diameter (Δdrel, p < 0.01, paired t-test vs the 
respective minimum diameter, n = 13) after relaxation. In most of the lymphatics 
analyzed, diaphragm relaxation did not cause the vessel diameter to return back to 
100% of their respective resting diameter. This is due to the fact that wash-out of KCl 
with a gentle flush of warm saline was performed only after the video recording was 
stopped, in order to avoid possible artifacts.  
 
Figure 4.21 Effect of diaphragmatic muscle contraction on perpendicular lymphatics next to the KCl 
injection site, which compressed showing greater sensitivity to the extrinsic pump. Panel on the left 
shows mean diameter  before and after striated diaphragmatic muscle fibers contraction and then after 
muscle relaxation. Panel on the right shows the extrinsic pump effect on lymphatic diameter , expressed 
as percentage of resting diameter. (** p < 0.01 vs resting diameter; §§ p < 0.01 vs lymphatic tone 
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A lower but significant effect (Fig 4.22) was found in larger perpendicular lymphatics 
with mean resting diameter of 186.67 ± 25.59 µm (no significant differences in diastolic 
diameter were found between the two populations of lymphatics) which decreased to 
143.85 ± 21.58 µm (p < 0.01, paired t-test vs resting diameter, n = 7) due to muscle 
contraction. After diaphragm relaxation lymphatic diameter reached 178.81 ± 26.59 µm 
(p < 0.01, paired t-test vs lymphatic diameter corresponding to the muscle contraction, n 
= 7). In those lymphatic vessels, on average, diameter decreased to 76.25 ± 2.4 % of 
resting diameter (Δd, p < 0.01, paired t-test vs the respective resting diameter set to 
100%, n = 7) and returned to 94.9 ± 1.9 % of resting diameter (Δdrel, p < 0.01, paired t-
test vs the respective minimum diameter, n = 7) after relaxation.  
Therefore, changes in lymphatic diameter were found to be two fold in the most 
sensitive perpendicular lymphatics (Hs, 100 - Δd = 46.4 ± 2.3 %) compared to the less 
sensitive ones (Ls, 100 – Δd = 23.5 ± 2.4 %, p < 0.01, unpaired t-test), probably due to 
different stiffness of the wall of lymphatic vessels, assuming that diaphragmatic 
muscular tissue is isotropic (224). 
 
Figure 4.22 Effect of diaphragmatic muscle contraction on perpendicular lymphatics next to the KCl 
injection site, which constricted showing less sensitivity to the extrinsic pump. Panel on the left shows 
mean diameter before and after striated diaphragmatic muscle fibers contraction and then after muscle 
relaxation. Panel on the right shows the extrinsic pump effect on lymphatic tone, expressed as percentage 
of resting diameter. (** p < 0.01 vs resting diameter; §§ p < 0.01 vs lymphatic tone corresponding to the 
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Perpendicular lymphatic vessels which were located far from the diaphragmatic 
contracting skeletal muscle fibers showed opposite behavior, expanding rather than 
compressing (Fig 4.19 green arrow, Fig 4.23). They had mean resting diameter of 
134.70 ± 20.70, not statistically different from the diastolic diameter of all the other 
perpendicular lymphatics (p = 0.172, one way ANOVA, 27 d.f.). Their mean diameter 
increased to 182.89 ± 28.27 µm (p < 0.01, paired t-test vs resting diameter, n = 8) and 
after skeletal diaphragmatic fiber relaxation lymphatic diameter decreased to 151.20 ± 
21.65 µm (p < 0.01, paired t-test vs lymphatic diameter corresponding to the muscle 
contraction, n = 8). On average, lymphatic diameter increased up to 135.8 ± 2.3 % of 
resting diameter (Δd, p < 0.01, paired t-test vs the respective resting diameter set to 
100%, n = 8) and then stepped back at 115.5 ± 5.5 % of resting diameter (Δdrel, p < 
0.01, paired t-test vs the respective expanded diameter, n = 8).  
 
Figure 4.23 Effect of diaphragmatic muscle contraction on perpendicular lymphatics next to the KCl 
injection site, which expanded due to the extrinsic pump. Panel on the left shows mean diameter before 
and after striated diaphragmatic muscle fibers contraction and then after muscle relaxation. Panel on the 
right shows the extrinsic pump effect on lymphatic tone, expressed as percentage of resting diameter. (** 
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4.5.2 Diaphragmatic muscle contraction effect on parallel lymphatics 
Similar to what observed for perpendicularly oriented vessels (Fig 4.19 – 4.23), skeletal 
diaphragmatic muscle contraction effect on longitudinally oriented lymphatics was also 
found to be dependent on the distance from the contracting site; however the effect on 
lymphatic segments was different. Indeed, as shown in Fig 4.24, the contraction of 
striated muscle next to the vessel caused shortening and distortion of the lymphatic 
vessel, with simultaneous enlargement of the lymphangions (Fig 4.24, orange arrow). 
 
Figure 4.24 Timeframe showing the effect of diaphragmatic muscle contraction on a parallel lymphatic 
(striated muscle fibers orientation highlighted by white dotted line) next to the injection site:1 sec 
corresponds to the injection frame, 4 sec to the maximal striated muscle fibers contraction and 54 sec to 
diaphragm relaxation. KCl was injected into the interstitium as indicated by yellow arrowhead. Orange 
arrow indicates the effect of diaphragmatic contraction on the vessel which expanded and shortened. 
Scalebar 500 µm. 
 
Pictures in Fig 4.25 highlight the selective effect of diaphragm contraction. In fact, as 
the lymphatic vessel next to the injecting site (orange arrow) shortened and expanded 
again, distant vessels (pink arrow) were not affected by local skeletal muscle 
contraction. 
1 4 54
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Figure 4.25 Timeframe showing the effect of diaphragmatic muscle contraction on parallel lymphatics 
(striated muscle fibers orientation highlighted by white dotted line) next or far to the injection site:1 sec 
corresponds to the injection frame, 7 sec to the maximal striated muscle fibers contraction and 64 sec to 
diaphragm relaxation. KCl was injected into the interstitium as indicated by yellow arrowhead. Orange 
arrow indicates the effect of diaphragmatic contraction on the vessel next to the contracting site, which 
expanded and shortened. On the contrary no effect was found in the far site as indicated by pink arrow. 
Scalebar 500 µm. 
 
The effect of local skeletal muscle contraction on parallel lymphatics is reported in Fig 
4.26 and 4.27. on average, lymphatic length between two reference points decreased to 
66.9 ± 3.0 % of resting one (Δl, p < 0.01, paired t-test vs the respective l0 set to 100%, n 
= 9) and thereafter returned to 81.8 ± 3.6 % of its resting length (p < 0.05, paired t-test 
vs the respective shortened length, n = 9) after skeletal muscle relaxation (Fig 4.26). 
 
Figure 4.26 Effect of skeletal diaphragmatic muscle contraction on parallel lymphatics next to the KCl 
injection site, which shortened due to the extrinsic pump. The graph shows the extrinsic pump effect on 
lymphatic length, expressed as percentage of resting one. (** p < 0.01 vs pre-contraction length, § p < 
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The mean resting diameter of parallel lymphatics was 117.71 ± 20.49 µm and expanded 
to 148.69 ± 23.31 µm (p < 0.01, paired t-test vs resting diameter, n = 11), decreasing 
back to 133.64 ± 23.86 µm (p < 0.05, paired t-test vs lymphatic diameter corresponding 
to the muscle contraction, n = 11) after diaphragmatic relaxation (Fig 4.27). On average, 
lymphatic diameter increased to 129.2 ± 3.6 % of resting diameter (Δd, p < 0.01, paired 
t-test vs the respective resting diameter set to 100%, n = 11) and then returned back to 
115.4 ± 6.1 % of resting diameter (Δdrel, p < 0.05, paired t-test vs the respective 
expanded diameter, n = 11).  
 
Figure 4.27 Effect of diaphragmatic muscle contraction on parallel lymphatics next to the KCl injection 
site, which expanded their cross-section due to the extrinsic pump. Panel on the left shows mean diameter 
length before and after striated diaphragmatic muscle fibers contraction and then after muscle relaxation. 
Panel on the right shows the extrinsic pump effect on lymphatic tone, expressed as percentage of resting 
diameter. (** p < 0.01 vs pre-contraction length; § p < 0.05 vs lymphatic length corresponding to the 
maximal diaphragmatic fibers contraction). 
 
Taken together these preliminary data indicate that local diaphragmatic skeletal muscle 
contractions actually modulate lymphatic function, by compressing and expanding 
segmental vessel diameter and/or length. Conversely to selective muscle contraction 
induced by local perivascular KCl injection, all the diaphragmatic striated fibers 
contract during spontaneous respiratory cycle. Thus, it is conceivable that each 
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simultaneously stretched by far ones as the diaphragmatic skeletal muscle contracts 
during inspiration One may hypothesize that perpendicular lymphatics which expand or, 
if any, only slightly compress (Ls) when perivascular fibers contract belong to the same 
class of vessel, whereas more compressing lymphatics (Hs) belong to a different class, 
probably distinguishable on the basis of the mechanical stiffness of the vessel wall, 
which still requires further investigations. 
 
4.5.3 Functional  parameters in lymphatics 
Mean resting diameter was significantly greater (161.82 ± 10.20 µm, p < 0.05, n = 28) 





lymphatics p value 
mean resting 
diameter (µm) 161.82 ± 10.20 117.71 ± 20.49 p < 0.05 
 Hs compress Ls compress  expand   
Stroke Volume 




- 49.18 ± 14.78 1961.51 ± 766.42 no 
Ejection 
Fraction (%) 71 ± 2** 41 ± 4 46 ± 2 64 ± 2
§§ p < 0.01 
Table 4.3 Lymphatics functional parameters. Stroke volume (SV) and diastolic volume load (DVL)) were 
normalized and also expressed as ejection fraction (EF). Compressing lymphatics are reported as Hs 
(more sensitive) and Ls (less sensitive) with respect to extrinsic pump effect on vessel tone. 
 
In perpendicular vessels SVs and DVLs were estimated (Table 4.3) in order to be 
compared with those of intrinsic propelling vessel (see Part I). No significant 
differences were found between SVs of perpendicular compressed lymphatics which 
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showed greater (Hs) or less (Ls) sensitivity to the extrinsic pump although the latter 
seem to be lower. Also vessels which expanded had comparable DVLs. On the contrary, 
EFs of Hs lymphatics was significantly higher than those of both constricted Ls (p < 
0.01, unpaired t-test) and expanded (p < 0.01, unpaired t-test) lymphatic vessels. 
If we compare the EFs of actively pumping lymphatics (43 ± 2 %) with those of Hs (71 
± 2 %) and Ls (41 ± 4 %) perpendicular lymphatics it is conceivable that intrinsic and 
extrinsic mechanisms support the whole lymph propulsion almost to the same extent, 
which is in good agreement with the reported amiloride induced reduction of pleura 
lymphatic flux of 40 %. 
 
4.5.4 Diaphragmatic muscle contraction effect on lymphatics intraluminal pressure 
As previously described, thoracic tissues are subjected to external influences which also 
affect lymphatic functions. Lymph drainage from serous cavities and lymph propulsion 
to the bloodstream by diaphragmatic lymphatics are affected by cardiac and respiratory 
cycles. In fact, local tissue displacement associated with cardiogenic oscillations plays a 
key role in promoting lymph formation and propulsion (54), as the active contraction of 
respiratory muscles is required to support an efficient lymphatic drainage from the 
thoracic tissues (56). Micropuncture experiments performed on rodents diaphragmatic 
lymphatics demonstrated that there are in- or out-of-phase cardiogenic swings of 
intraluminal lymphatic pressure ranging from ~ -20 to ~ + 10 cm H2O (66; 54) affecting 
intralymphatic pressure gradients. Also during spontaneous inspiration mechanical 
stresses arise in intercostals and diaphragmatic tissues resulting in Plymph and Pin, 
oscillations which are transmitted to the lymphatic vessel lumen as pressure gradients 
(56). 
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At present, intrinsic intraluminal pressure oscillation have been recorded only 
occasionally (85). We had been able to measure intaluminal pressure only in lymphatic 
tracts adjacent to ones showing intrinsic pumping activity. In fact, one cannot exclude 
that the pipette insertion maneuver might hinder the intrinsic contractile capacity of the 
vessel wall. This is why Fig 4.28 (violet arrowhead) shows the damped pressure 
oscillation profile due to the intrinsic pumping activity in the lymphangion adjacent to 
the analyzed one, thus confirming the cyclic effect of the intrinsic pump on lymphatic 
function. 
 
Figure 4.28 Example of intraluminal pressure changes due to intrinsic pumping activity (violet 
arrowhead) in an adjacent lymphangion to the one in which the micropipette has been inserted. In this 
case.  
 
Diaphragm contraction can either induce an increase or a decrease in intraluminal 
lymphatic pressure, as reported in Fig 4.29 (green arrowheads). Data reported refer to 
intraluminal pressure recordings in two perpendicular lymphatic vessels which were not 
distinguishable from an anatomical point of view. Pressure data represent the early part 
of a still ongoing work, which requires further analysis to better evaluate the complete 
functional behavior of the extrinsic pump. As the animals were temporarily 
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pressure traces and the high frequency oscillations are of cardiogenic origin (Fig 4.29 
red arrows). 
 
Figure 4.29 Example of intraluminal pressure changes due to extrinsic pump (green arrowheads) after 
diaphragmatic muscle contraction (blue arrows indicate the KCl injections time into interstitium) next to 
perpendicular lymphatic vessels. In A diaphragm contraction induced a ΔP decrease of -14.37 cmH2O, 
whereas in B the diaphragm contraction induced a ΔP increase of + 14.95 cmH2O. Red arrows indicate 
the cardiogenic effect on lymphatic intraluminal pressure. 
 
Intraluminal pressure changes externally induced by diaphragmatic striated muscle 
contraction and resulting as perpendicular lymphatics expansion and/or contraction 
were plotted in a ΔP vs Δd graph, distinguishing between data grouped as Hs (Fig 4.30 
B) and Ls or expanding (Fig 4.30 A) lymphatics. Both populations were fitted by a 
linear trend (A: y = 0.37x -5.44, r2 = 0.58, n = 7; B: y = 0.17 – 27.00, r2 = 0.54, n = 7), 
suggesting the existence of two separated populations. In fact, the Ls and expanding 
lymphatics (Fig 4.30 A) had an extreme variability in intraluminal pressure changes and 
data were fitted by a linear trend which had a greater slope, indicating that small 
changes in diameter induced a major shift in intraluminal lymphatic pressure. On the 
contrary, data from Hs lymphatics (Fig 4.30 B) were fitted by a linear trend which had a 
smaller slope, thus resulting in weak changes in intraluminal lymphatic pressure 
induced by larger diameter length reductions. Particularly, these vessels also showed 
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Figure 4.30 Relationship between changes in intraluminal lymphatic pressure (ΔP) and diameter (Δd) in 
perpendicular lymphatics. The pressure data were plotted vs Δd. A correspond to lLs or expanding 
lymphatic vessels, whereas B represent ΔP changes in Hs vessels. 
 
Early results from preliminary intraluminal pressure changes recorded during 
diaphragmatic muscle contraction suggest the existence of two separated population of 
perpendicular lymphatics, as previously hypothesized in Paragraph 4.5.1. The ΔP/Δd 
ratio is proportional to the reciprocal value of the vessel compliance (ΔV/ΔP) which is 
an intrinsic feature of the vessel wall. According to what previously published (224) 
these data confirm the existence of perpendicular diaphragmatic lymphatics which are 
undistinguishable from a morphological point of view but may possess lower (Fig 6.12 
A) or higher (Fig 6.12 B) compliance. 
 
Data from intraluminal pressure recordings of parallel lymphatics also showed a single 
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Figure 4.31 Relationship between changes in intraluminal lymphatic pressure (ΔP) and volume changes 
(ΔV) in parallel lymphatics. 
 
In conclusion, lymph formation in initial lymphatics and its propulsion along the initial 
lymphatic network are mainly sustained by hydrostatic pressure gradients, as lymphatics 
offer no resistance to fluid and macromolecules to enter the lumen, which are strongly 
affected by extrinsic and/or intrinsic forces. Further experiments will be required to 
understand the relative role and the interaction between the intrinsic and extrinsic 
mechanism by treating the vessels and the perivascular interstitium with either 
acetylcholine or noreprinephrine. In fact acetylcholine is able to evoke skeletal muscle 
contraction (245), whereas it causes hyperpolarization in lymphatic smooth muscle 
cells, while noreprinephrine only induces lymphatic smooth muscle depolarization 




























The identification of spontaneous contractile activity in lymphatic vessels of the 
diaphragm, a muscular tissue always subjected to rhythmical movements, is somehow 
surprising. Indeed, these active vessels are mostly located at the far periphery of the 
diaphragm, in a region in close continuity with the abdominal wall. Moreover, these 
lymphatic loops are endowed with at least four kinds of vessel. Nevertheless, this active 
pumping mechanism is not the only responsible for the whole pleural lymphatic flux, 
given that most of the lymphatic diaphragmatic network is located in the more central 
muscular and tendineous regions, whose movements are more accentuated than those of 
the far periphery during the respiratory cycle. Indeed, these lymphatics are mostly 
subjected to the extrinsic pumping mechanism due to the contraction of the striated 
muscle fibers surrounding them. In conclusion, at least in the diaphragm, the two 
different strategies of lymph propulsion (intrinsic and extrinsic mechanisms) do coexist, 
but their relative importance seems to be spatially segregated: the intrinsic mechanism 
seems to be confined to those lymphatic loops in the periphery, while in more central 
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